<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">106265</article-id>
<article-id pub-id-type="doi">10.7554/eLife.106265</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.106265.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Developmental Biology</subject>
</subj-group>
</article-categories><title-group>
<article-title>Integrated transcriptomic analysis of human induced pluripotent stem cell-derived osteogenic differentiation reveals a regulatory role of KLF16</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ru</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Xianxiao</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kriti</surname>
<given-names>Divya</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cohen</surname>
<given-names>Ninette</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Souza</surname>
<given-names>Sunita</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaniel</surname>
<given-names>Christoph</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
<xref ref-type="aff" rid="a9">9</xref>
<xref ref-type="aff" rid="a10">10</xref>
<xref ref-type="aff" rid="a11">11</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3412-221X</contrib-id>
<name>
<surname>Motch Perrine</surname>
<given-names>Susan M</given-names>
</name>
<xref ref-type="aff" rid="a12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuo</surname>
<given-names>Sharon</given-names>
</name>
<xref ref-type="aff" rid="a13">13</xref>
<xref ref-type="aff" rid="a14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pichurin</surname>
<given-names>Oksana</given-names>
</name>
<xref ref-type="aff" rid="a15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinto</surname>
<given-names>Dalila</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Housman</surname>
<given-names>Genevieve</given-names>
</name>
<xref ref-type="aff" rid="a16">16</xref>
<xref ref-type="aff" rid="a17">17</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0717-6722</contrib-id>
<name>
<surname>Holmes</surname>
<given-names>Greg</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schadt</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1376-6916</contrib-id>
<name>
<surname>van Bakel</surname>
<given-names>Harm</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jabs</surname>
<given-names>Ethylin Wang</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a7">7</xref>
<xref ref-type="aff" rid="a15">15</xref>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5512-9651</contrib-id>
<name>
<surname>Wu</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a15">15</xref>
<xref ref-type="aff" rid="a19">19</xref>
<email>wu.meng@mayo.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01nprxv78</institution-id><institution>Mount Sinai Genomics, Sema4</institution></institution-wrap>, <city>Stamford</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rmrcq20</institution-id><institution>Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of British Columbia</institution></institution-wrap>, <city>Vancouver</city>, <country country="CA">Canada</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02bxt4m23</institution-id><institution>Division of Cytogenetics and Molecular Pathology, Zucker School of Medicine at Hofstra/Northwell, Northwell Health Laboratories</institution></institution-wrap>, <city>Lake Success</city>, <country country="US">United States</country></aff>
<aff id="a7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02r3e0967</institution-id><institution>St Jude Children’s Research Hospital</institution></institution-wrap>, <city>Memphis</city>, <country country="US">United States</country></aff>
<aff id="a9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0317dzj93</institution-id><institution>Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Mount Sinai Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04p491231</institution-id><institution>Department of Anthropology, Pennsylvania State University</institution></institution-wrap>, <city>University Park</city>, <country country="US">United States</country></aff>
<aff id="a13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/017zqws13</institution-id><institution>Department of Biomedical Sciences, University of Minnesota</institution></institution-wrap>, <city>Duluth</city>, <country country="US">United States</country></aff>
<aff id="a14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a33b393</institution-id><institution>Technological Primates Research Group, Max Planck Institute for Evolutionary Anthropology</institution></institution-wrap>, <city>Leipzig</city>, <country country="DE">Germany</country></aff>
<aff id="a15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Department of Clinical Genomics, Mayo Clinic</institution></institution-wrap>, <city>Rochester</city>, <country country="US">United States</country></aff>
<aff id="a16"><label>16</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024mw5h28</institution-id><institution>Section of Genetic Medicine, Department of Medicine, University of Chicago</institution></institution-wrap>, <city>Chicago</city>, <country country="US">United States</country></aff>
<aff id="a17"><label>17</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a33b393</institution-id><institution>Department of Primate Behavior and Evolution, Max Planck Institute for Evolutionary Anthropology</institution></institution-wrap>, <city>Leipzig</city>, <country country="DE">Germany</country></aff>
<aff id="a18"><label>18</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Department of Microbiology, Icahn School of Medicine at Mount Sinai</institution></institution-wrap>, <city>New York</city>, <country country="US">United States</country></aff>
<aff id="a19"><label>19</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qp3tb03</institution-id><institution>Department of Biochemistry and Molecular Biology, Mayo Clinic</institution></institution-wrap>, <city>Rochester</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Sugimura</surname>
<given-names>Rio</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>The University of Hong Kong</institution>
</institution-wrap>
<city>Pok Fu Lam</city>
<country country="HK">Hong Kong</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Cheah</surname>
<given-names>Kathryn Song Eng</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Hong Kong</institution>
</institution-wrap>
<city>Hong Kong</city>
<country country="HK">Hong Kong</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-05-28">
<day>28</day>
<month>05</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP106265</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-02-21">
<day>21</day>
<month>02</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-01-27">
<day>27</day>
<month>01</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.11.579844"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Ru et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Ru et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-106265-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>Osteogenic differentiation is essential for bone development, metabolism, and repair; however, the underlying regulatory relationships among genes remain poorly understood. To elucidate the transcriptomic changes and identify novel regulatory genes involved in osteogenic differentiation, we differentiated mesenchymal stem cells (MSCs) derived from 20 human iPSC lines into preosteoblasts (preOBs) and osteoblasts (OBs). We then performed transcriptome profiling of MSCs, preOBs and OBs. The iPSC-derived MSCs and OBs showed similar transcriptome profiles to those of primary human MSCs and OBs, respectively. Differential gene expression analysis revealed global changes in the transcriptomes from MSCs to preOBs, and then to OBs, including the differential expression of 840 genes encoding transcription factors (TFs). TF regulatory network analysis uncovered a network comprising 451 TFs, organized into five interactive modules. Multiscale embedded gene co-expression network analysis (MEGENA) identified gene co-expression modules and key network regulators (KNRs). From these analyses, <italic>KLF16</italic> emerged as an important TF in osteogenic differentiation. We demonstrate that overexpression of <italic>Klf16</italic> in vitro inhibited osteogenic differentiation and mineralization, while <italic>Klf16<sup>+/-</sup></italic> mice exhibited increased bone mineral density, trabecular number, and cortical bone area. Our study underscores the complexity of osteogenic differentiation and identifies novel regulatory genes such as <italic>KLF16</italic>, which plays an inhibitory role in osteogenic differentiation both in vitro and in vivo.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>bone</kwd>
<kwd>induced pluripotent stem cell</kwd>
<kwd>mesenchymal stem cell</kwd>
<kwd>osteoblast</kwd>
<kwd>RNA sequencing</kwd>
<kwd>differential gene expression</kwd>
<kwd>transcription factor</kwd>
<kwd>single-cell RNA-seq</kwd>
<kwd>network analysis</kwd>
<kwd>systems biology</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Additional author added, author affiliations updated, author order revised, text revised, figures revised, supplemental figures and tables revised with new data added.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of lineages, including osteoblasts (OBs), chondrocytes, and adipocytes (<xref ref-type="bibr" rid="c69">Pittenger et al., 1999</xref>). The multilineage potential, self-renewal capacity, and immune-modulation functions of MSCs have made them a promising therapeutic tool for cell therapies and regenerative medicine (<xref ref-type="bibr" rid="c10">Bruder et al., 1994</xref>; <xref ref-type="bibr" rid="c26">Han et al., 2019</xref>). Osteogenic differentiation from MSCs plays a pivotal role in bone development, homeostasis, and repair. This process replenishes the pool of osteoblasts and ensures that there are enough cells available for bone formation and repair. It is highly regulated by multiple mechanisms and previous research has highlighted the roles of various genes, including those coding for transcription factors (TFs) and signaling pathways such as TGF-β/BMP, Notch, Hedgehog, Wnt, Hippo, and estrogen receptor signaling (<xref ref-type="bibr" rid="c90">Thomas and Jaganathan, 2022</xref>). Precise and robust transcriptional regulation required during osteogenic differentiation is achieved by networks of transcriptional regulators. For example, <italic>RUNX2</italic> is a master transcription factor in early osteogenic differentiation (<xref ref-type="bibr" rid="c38">Komori et al., 1997</xref>; <xref ref-type="bibr" rid="c77">Schroeder et al., 2005</xref>). TFs <italic>SP7, ATF4, TEAD4</italic>, and <italic>KLF4</italic> work alongside <italic>RUNX2</italic> to regulate osteogenesis (<xref ref-type="bibr" rid="c63">Nakashima et al., 2002</xref>; <xref ref-type="bibr" rid="c87">Suo et al., 2020</xref>; <xref ref-type="bibr" rid="c97">Yang et al., 2004</xref>; <xref ref-type="bibr" rid="c100">Yu et al., 2021</xref>). The broader TF interplay in osteogenic differentiation remains largely uncharted, even with insights from ENCODE (Encyclopedia of DNA Elements) data that reveal the co-association of human TFs in a combinatorial and context-specific manner (<xref ref-type="bibr" rid="c23">Gerstein et al., 2012</xref>), revealing a need for further investigation.</p>
<p>Transcriptome profiling can uncover the key genes essential for bone formation and growth, offering valuable insights into bone development and the underlying mechanisms of bone-related diseases. However, due to the invasiveness required to obtain human primary MSCs and the suboptimal conditions for preserving available samples, large-scale human transcriptomics projects, such as GTEx, do not include data from bone and cartilage. Furthermore, studies focusing on these tissues are often limited to disease contexts. Induced pluripotent stem cell (iPSC)-derived systems, with their pluripotency and differentiation capabilities, offer an avenue for studying skeletal development. iPSC-derived sclerotome models have been utilized to identify gene expression signatures and regulatory mechanisms crucial to key developmental stages of endochondral ossification (<xref ref-type="bibr" rid="c42">Lamande et al., 2023</xref>; <xref ref-type="bibr" rid="c62">Nakajima et al., 2018</xref>; <xref ref-type="bibr" rid="c88">Tani et al., 2023</xref>). Previous studies for osteogenic differentiation from iPSC-derived MSCs included only one to two MSC cell lines (<xref ref-type="bibr" rid="c58">Matsuda et al., 2020</xref>; <xref ref-type="bibr" rid="c72">Rauch et al., 2019</xref>), limiting their power for comprehensive transcriptomic analyses. In this study, 20 human iPSC lines, each from a healthy individual, were used to investigate osteogenic differentiation of MSCs by RNA sequencing (RNA-seq) at three key stages: MSC, preosteoblast (preOB), and osteoblast (OB). Our findings highlight dynamic gene expression changes during osteogenic differentiation and identify the regulatory role of TF KLF16 as an inhibitor of osteogenic differentiation. This work provides insights into osteogenic differentiation and sheds light on novel therapeutic targets for bone diseases.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Transcriptome profiles of human iPSC-derived MSCs and OBs are similar to those of primary MSCs and OBs</title>
<p>Human iPSCs were generated from peripheral blood mononuclear cells (PBMCs) or skin fibroblasts of 20 healthy individuals (9 males and 11 females) and differentiated into MSC, preOB, and OB stages (<xref rid="fig1" ref-type="fig">Figure 1A</xref>; <xref ref-type="fig" rid="figs1">Supplementary Figure 1A, 1B</xref>, and <xref ref-type="fig" rid="figs1">1H</xref>; Supplementary Table 1). To abrogate the epigenetic memory from their source cell types and minimize in vitro transcriptional and differentiation heterogeneity, the established iPSC lines were cultured for at least 16 passages and underwent quality control (<xref ref-type="bibr" rid="c70">Polo et al., 2010</xref>). The iPSCs were then differentiated into MSCs and sorted for the CD105+/CD45- cell population (<xref ref-type="bibr" rid="c24">Giuliani et al., 2011</xref>; <xref ref-type="bibr" rid="c36">Kang et al., 2015</xref>) (<xref ref-type="fig" rid="figs1">Supplementary Figure 1C</xref>). No significant differences were found in the percentage of this cell population between PBMC and fibroblast origins (<xref ref-type="fig" rid="figs1">Supplementary Figure 1D</xref>). After two weeks of expansion, the iPSC-derived MSCs were confirmed to exhibit mesenchymal characteristics, evidenced by strong expression of positive MSC surface markers (CD29, CD73, CD90, and CD105) and minimal expression of negative markers (CD31, CD34, and CD45) at both the protein level by flow cytometry (<xref ref-type="fig" rid="figs1">Supplementary Figure 1E</xref> and <xref ref-type="fig" rid="figs1">1F</xref>) and mRNA level by RNA-seq (<xref ref-type="fig" rid="figs1">Supplementary Figure 1G</xref>). The MSCs were cultured in osteogenic differentiation medium for 7 days to generate preOBs and for 21 days to produce OBs. After 21 days of osteogenic differentiation, the OBs showed alkaline phosphatase (ALP) enzyme activity and mineralization, indicating the state of functional OBs (<xref rid="fig1" ref-type="fig">Figure 1B</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Generation of healthy human iPSCs and osteogenic differentiation transcriptomic data.</title>
<p><bold>(A)</bold> Flowchart of iPSC establishment, iPSC-derived MSC generation, MSC to OB differentiation (preOBs, preosteoblasts; OBs, osteoblasts), and RNA-seq data generation and analyses. <bold>(B)</bold> In vitro osteogenic differentiation of MSCs (Day 0), preOBs (Day 7), and OBs (Day 21) stained with alkaline phosphatase (ALP), alizarin red, and von Kossa. <bold>(C)</bold> Expression level of known osteogenic genes at the three osteogenic stages. Data are shown as mean ± SEM. * MSC vs preOB, # preOB vs OB, or + MSC vs OB, adjusted p value &lt; 0.0001. <bold>(D)</bold> Principal component analysis (PCA) of RNA-seq data from our iPSC-derived MSCs and differentiated OBs as well as previously published human primary MSCs and OBs, iPSCs, and other tissues in GTEx.</p></caption>
<graphic xlink:href="579844v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>MSCs, preOBs, and OBs derived from the 20 individuals were harvested and a total of 60 RNA-seq libraries were generated (<xref rid="fig1" ref-type="fig">Figure 1A</xref>; Supplementary Table 1). We initially employed bulk RNA-seq rather than single-cell RNA-seq (scRNA-seq) because the latter recovers only sparse transcriptional data from individual cells, thus limiting comprehensive expression analysis and the development of robust prediction models for regulatory and gene co-expression networks (<xref ref-type="bibr" rid="c50">Li and Wang, 2021</xref>). RNA-seq data revealed increased expression of OB lineage markers (<italic>ALPL, COL1A1, RUNX2, SPARC, OMD,</italic> and <italic>OGN</italic>) with characteristic temporal expression patterns during osteogenic differentiation (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). We further compared our MSC and OB RNA-seq datasets with previously published human primary MSC and OB datasets, human iPSC datasets, and GTEx datasets for different tissues derived from the three germ layers (ectoderm, endoderm, and mesoderm) and germ cells (<xref ref-type="bibr" rid="c1">Al-Rekabi et al., 2016</xref>; <xref ref-type="bibr" rid="c2">Ardlie et al., 2015</xref>; <xref ref-type="bibr" rid="c55">Ma et al., 2019</xref>; <xref ref-type="bibr" rid="c74">Roforth et al., 2015</xref>; <xref ref-type="bibr" rid="c75">Rojas-Peña et al., 2014</xref>). By principal component analysis (PCA), our MSC and OB datasets clustered with those of published primary MSCs and OBs, respectively, and were discrete from iPSCs and other tissue datasets, further validating the cell identities of our MSCs and OBs (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
</sec>
<sec id="s2b">
<title>Differential transcription profiles of human iPSC-derived MSCs, preOBs, and OBs</title>
<p>During in vitro osteogenic differentiation, we detected the expression of 17,795 unique genes across all stages, of which 79% were protein-coding and 21% were noncoding (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). Seventy percent or 9,724 of the protein-coding genes were differentially expressed (DE) between the osteogenic stages (MSC to preOB, or preOB to OB) (fold change ≥ 1.2 and adjusted p value ≤ 0.05). Sixty percent (2,297) of the noncoding genes also were DE (<xref rid="fig2" ref-type="fig">Figure 2A</xref>), of which 2,249 (98% of DE noncoding) were long noncoding RNA (lncRNA) genes. By intersecting with the human TF repertoire including over 1,600 known or likely human TFs (<xref ref-type="bibr" rid="c43">Lambert et al., 2018</xref>), we found that nine percent (840 genes) of the DE coding genes were TFs (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). A chi-square test revealed a significant correlation between TFs and differentially expressed genes (DEGs) (X<sup>2</sup> = 27.4, p value &lt; 0.0001). There were 5,715 up-regulated genes and 4,409 down-regulated genes from the MSC to the preOB stage, and 3,342 up-regulated genes and 2,835 down-regulated genes from the preOB to the OB stage, revealing that the majority of the DEGs were up-regulated during osteogenic differentiation (<xref rid="fig2" ref-type="fig">Figure 2C-E</xref>; Supplementary Table 2). Among the top statistically significant DEGs were known osteogenesis-associated genes, including a SMAD ubiquitination regulatory factor <italic>SMURF2</italic> (<xref ref-type="bibr" rid="c41">Kushioka et al., 2020</xref>), natriuretic peptide precursor B <italic>NPPB</italic> (<xref ref-type="bibr" rid="c3">Aza-Carmona et al., 2014</xref>), hypoxia-inducible factor 3 subunit alpha <italic>HIF3A</italic> (<xref ref-type="bibr" rid="c107">Zhu et al., 2014</xref>), a TF <italic>ZBTB16</italic> (<xref ref-type="bibr" rid="c65">Onizuka et al., 2016</xref>), a Wnt signaling pathway family member <italic>WNT7B</italic> (<xref ref-type="bibr" rid="c99">Yu et al., 2020</xref>), osteoinductive factor <italic>OGN</italic> (<xref ref-type="bibr" rid="c40">Kukita et al., 1990</xref>), a SFRP family (modulators of Wnt signaling) member <italic>SFRP2</italic> (<xref ref-type="bibr" rid="c96">Yang et al., 2020</xref>), and a glycoprotein member of the glycosyl hydrolase 18 family <italic>CHI3L</italic> (<xref ref-type="bibr" rid="c13">Chen et al., 2017</xref>). There were also many genes with no defined function in bone, including those that play critical roles in RNA binding activity (<italic>EBNA1BP2</italic>), maintenance of protein homeostasis (<italic>PSMD2</italic>), arachidonic acid metabolism (<italic>PRXL2B</italic>), hemostasis and antimicrobial host defense (<italic>FGB</italic>), embryonic and induced pluripotent stem cells (<italic>PCSK2</italic>), as well as cell proliferation, differentiation, and migration (<italic>FGFBP1</italic>). A greater number of DEGs with larger changes in gene expression were identified between the MSC and preOB stages compared to the changes between the preOB and OB stages, even though the differentiation interval was half as long between the MSC and preOB stages (one week) as it was between the preOB and OB stages (two weeks) (<xref rid="fig2" ref-type="fig">Figure 2C-E</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Gene expression profile during osteogenic differentiation.</title>
<p><bold>(A)</bold> Gene expression during osteogenic differentiation with the total number of expressed genes and percentages of expressed coding and noncoding genes (middle). Number and percentages of differentially expressed (DE) and non-differentially expressed (non-DE) coding genes (left; TFs and non-TFs (white pie chart)) and of noncoding genes (right). <bold>(B)</bold> DEGs during osteogenic differentiation with total and percentages of coding and noncoding genes (left), and TFs and non-TFs (right). <bold>(C)</bold> Heatmap showing hierarchical clustering of 60 RNA-seq datasets from 20 iPSC-derived MSC, preOB, and OB lines (columns) and significant differentially expressed genes (DEGs) (rows), fold change ≥ 1.2 and adjusted p value &lt; 0.05. Up-regulated and down-regulated gene expression is colored in red and blue, respectively. <bold>(D)</bold> and <bold>(E)</bold> Volcano plots illustrate the distribution of down- and up-regulated genes (blue and red, respectively) with adjusted p values and fold changes when comparing gene differential expression from MSC to preOB in <bold>(D)</bold> and preOB to OB stages in <bold>(E)</bold>. Cutoffs of fold change ≥ 1.2 and adjusted p value &lt; 0.05 were applied to define DEGs. The total number of up-regulated and down-regulated genes are noted at the top (red and blue, respectively). The genes are labeled for the top five up-regulated (red, bottom right), downregulated (blue, bottom left), and statistically significant down-regulated (blue, top left) and up-regulated (red, top right).</p></caption>
<graphic xlink:href="579844v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>Transcription factor regulatory network during human osteogenic differentiation</title>
<p>By PCA, we found that the DEG expression profiles segregated all of the samples by their differentiation stage, with MSCs being most distinct from preOBs and OBs, which is consistent with the larger number of DEGs present between the MSC and preOB stages than the later stages (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). Of note, when we used only the 840 differentially expressed TFs, their expression profiles also segregated the three osteogenic stages (<xref rid="fig3" ref-type="fig">Figure 3B</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>TF regulatory network in osteogenic differentiation.</title>
<p><bold>(A)</bold> Principal component analysis (PCA) of all 20 healthy cell lines at three stages of osteogenic differentiation using all differentially expressed genes (DEGs). <bold>(B)</bold> PCA using only differentially expressed TF genes. <bold>(C)</bold> TF regulatory network during osteogenic differentiation. Each node represents a TF, with known bone formation associated regulators underlined in red. Two nodes are connected by a line where ReMap data suggest regulation and our RNA-seq data suggest the association between them. Nodes labeled with the gene name represent the top 100 strongest TFs based on betweenness centrality. The size of the nodes reflects the regulation strength of the TF, with the top 5 strongest circled in pink. <bold>(D)</bold> and <bold>(E)</bold> Top significantly enriched GO BP terms in <bold>(D)</bold> and Reactome pathways in <bold>(E)</bold> of TFs in each network module.</p></caption>
<graphic xlink:href="579844v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>TFs regulate not only the transcription of other protein-coding genes and noncoding RNA genes but also their own expression. We focused on the TF biological cooperativity with respect to TF-TF regulation, which has not been extensively investigated in osteogenic differentiation due to the limited availability of DNA-binding data from MSCs, preOBs, and OBs. To predict the TF-TF regulatory network during osteogenic differentiation, we constructed a network using our RNA-seq data and the database ReMap, which integrated and analyzed 5,798 human ChIP-seq and ChIP-exo datasets from public sources providing a transcriptional regulatory repertoire to predict target genes (<xref ref-type="bibr" rid="c14">Chèneby et al., 2020</xref>). ReMap covers 1,135 transcriptional regulators, including primarily TFs as well as coactivators, corepressors, and chromatin-remodeling factors, with a catalog of 165 million binding peaks. We filtered out TFs that lacked associations in ReMap, as they are less likely to have direct binding activities in regulating the transcription of TF genes. To further assure the reliability and accuracy of the regulatory relationships in our osteogenic differentiation datasets, we then assessed regulations among them by computing correlation coefficients of gene expression, resulting in 451 TFs in the network. After the application of a partitioning algorithm, the network was organized into five interconnected modules (<xref ref-type="bibr" rid="c5">Bastian et al., 2009</xref>) (<xref rid="fig3" ref-type="fig">Figure 3C</xref>; Supplementary Table 3). The network showed that TFs potentially regulate other TFs both internal and external to their respective modules, revealing a highly complex network of transcriptional regulators. We identified the top 100 TFs determined by their betweenness centrality, which coincided with their power to regulate others in the network (<xref ref-type="bibr" rid="c5">Bastian et al., 2009</xref>) (<xref rid="fig3" ref-type="fig">Figure 3C</xref>; Supplementary Table 3). Among them, TF genes known to regulate osteogenic differentiation were present in different modules, such as <italic>ATF4</italic> (<xref ref-type="bibr" rid="c97">Yang et al., 2004</xref>) in Module 1, <italic>FOSL1</italic> (<xref ref-type="bibr" rid="c39">Krum et al., 2010</xref>) in Module 2, <italic>ZEB1</italic> (<xref ref-type="bibr" rid="c22">Fu et al., 2020</xref>) in Module 3, and <italic>TEAD4</italic> (<xref ref-type="bibr" rid="c87">Suo et al., 2020</xref>) in Module 5 (Supplementary Table 3). Of interest, TF <italic>KLF16</italic> in Module 5, which previously was not demonstrated to be involved in bone formation and development, was identified as a key player in the regulatory network. It ranks as the fifth top regulator, directly interacting with the second top regulator <italic>TEAD4</italic>, and shows a high degree of association with 315 TFs (Supplementary Table 3).</p>
<p>Gene ontology (GO) and Reactome pathway (RP) analyses revealed regulatory functions and pathways specific to each module (FDR &lt; 0.05; <xref rid="fig3" ref-type="fig">Figure 3D</xref> and <xref rid="fig3" ref-type="fig">3E</xref>; Supplementary Table 3). As examples for the GO biological process (BP) terms, Module 3 was enriched for skeletal muscle cell differentiation and muscle structure development, associated with 15 TF genes (<italic>ZBTB18</italic>, <italic>MEF2A</italic>, <italic>EGR1</italic>, <italic>TCF7L2</italic>, <italic>EGR2</italic>, <italic>EPAS1</italic>, <italic>SRF</italic>, <italic>ZBTB42</italic>, <italic>ETV1</italic>, <italic>FOS</italic>, <italic>RBPJ</italic>, <italic>NR4A1</italic>, <italic>SIX4</italic>, <italic>ID3</italic>, <italic>ATF3</italic>), as well as the term fat cell differentiation and six associated TF genes (<italic>ATF2</italic>, <italic>NR4A1</italic>, <italic>TCF7L2</italic>, <italic>EGR2</italic>, <italic>PPARG</italic>, <italic>GLIS1</italic>). Module 5, containing <italic>KLF16</italic>, was enriched for terms ncRNA transcription and positive regulation of the Notch signaling pathway (<xref rid="fig3" ref-type="fig">Figure 3D</xref>), which is essential in bone development and metabolism (<xref ref-type="bibr" rid="c53">Liu et al., 2016</xref>).</p>
<p>In addition, each of the modules was enriched for GO cellular component (CC) terms of various complexes. Module 2 was enriched for the term ESC/E(Z) complex, a multimeric protein complex that can interact with several noncoding RNAs, a vital gene silencing complex regulating transcription, and an effector of response to ovarian steroids (<xref ref-type="bibr" rid="c21">Dubey et al., 2017</xref>) (<xref ref-type="fig" rid="figs2">Supplementary Figure 2A</xref>). The modules were enriched for different GO molecular function (MF) terms of receptor binding of various hormones, including androgen, estrogen, glucocorticoid, and thyroid hormone receptor binding (<xref ref-type="fig" rid="figs2">Supplementary Figure 2B</xref>), providing more evidence of the crosstalk between bone and gonads (<xref ref-type="bibr" rid="c67">Oury, 2012</xref>). By RP analysis, Module 2 was associated with activation of HOX genes during differentiation, aligning with their well-established roles in osteogenic differentiation of MSCs and skeletogenesis (<xref ref-type="bibr" rid="c79">Seifert et al., 2015</xref>). Module 5 was associated with signaling by TGF-beta family members, and the SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). These results revealed the complex and robust nature of TF regulatory networks during osteogenic differentiation.</p>
</sec>
<sec id="s2d">
<title>Identification of key regulators in the co-expression network of human osteogenic differentiation</title>
<p>We performed multiscale embedded gene co-expression network analysis (MEGENA) to identify gene co-expression structures (i.e., modules) as well as key network regulators (KNRs) (<xref ref-type="bibr" rid="c81">Song and Zhang, 2015</xref>; <xref ref-type="bibr" rid="c29">Holmes et al., 2020</xref>). MEGENA was conducted on the RNA-seq data from the samples at the MSC, preOB, and OB differentiation stages and identified 168 gene co-expression modules (FDR ≤ 0.05, <xref rid="fig4" ref-type="fig">Figure 4A</xref>; Supplementary Table 4). We then identified potential KNRs that were predicted to modulate a large number of DEGs in the network by key regulator analysis (<xref ref-type="bibr" rid="c102">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="c103">Zhang and Zhu, 2013</xref>). Many modules enriched for DEGs and their associated KNRs recapitulated known osteogenic factors. For example, Module M204, comprised of 85 genes, was significantly enriched for down-regulated DEGs (MSC to preOB, fold enrichment = 1.80, adjusted p value = 1.58E-2; preOB to OB, fold enrichment = 2.29, adjusted p value = 1.08E-3) (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). More than 9% (8 genes) of the DEGs in M204 are related to bone development and metabolism (Supplementary Table 4). Three (<italic>PHLDA2</italic>, <italic>RHOC</italic>, <italic>PFN1</italic>) out of the eight genes were identified as KNRs (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). The expression of <italic>PHLDA2</italic> is associated with skeletal growth and childhood bone mass (<xref ref-type="bibr" rid="c47">Lewis et al., 2012</xref>). Knockdown of RHOC dramatically inhibits osteogenesis (<xref ref-type="bibr" rid="c105">Zheng et al., 2019</xref>). <italic>PFN1</italic>, a member of the profilin family of small actin-binding proteins, is known to regulate bone formation. The loss of PFN1 function causes early onset of Paget’s disease of bone, a disease with impaired osteoclast and osteoblast differentiation (Scotto <xref ref-type="bibr" rid="c78">di Carlo et al., 2020</xref>). We also examined the overlap of the genes in M204 with the genes from genome-wide association studies with significant signals for bone area (B-area), bone mineral density (BMD), and hip geometry (<xref ref-type="bibr" rid="c31">Hsu et al., 2019</xref>; <xref ref-type="bibr" rid="c61">Morris et al., 2019</xref>; <xref ref-type="bibr" rid="c85">Styrkarsdottir et al., 2019</xref>), and found five genes, <italic>CYFIP1</italic>, <italic>MMD</italic>, <italic>PELO</italic>, <italic>PRSS23</italic>, and <italic>SNX13</italic>.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Gene co-expression network in osteogenic differentiation.</title>
<p><bold>(A)</bold> Sunburst plots represent the hierarchy structure of the MEGENA co-expression network constructed on gene expression during the osteogenic differentiation. The structure is shown as concentric rings where the center ring represents the parent modules, and outer rings represent smaller child modules. Subnetwork modules are colored according to the enrichment of differential gene expression between stages (FDR &lt; 0.05; left, MSC to preOB; right, preOB to OB; blue, down-regulated; red, up-regulated; cyan, both up-and down-regulated). The subnetwork branch for Module M204 is outlined and labeled. <bold>(B)</bold> Co-expression network Module M204. Diamonds indicate KNR genes, and circles indicate non-KNR genes. Blue indicates DEGs from MSC to preOB stages, red indicates DEGs from preOB to OB stages, and cyan indicates shared DEGs for both comparisons. Genes known to be related to bone are in red.</p></caption>
<graphic xlink:href="579844v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>As TFs are known to be fundamental to the osteogenic process, we were particularly interested in finding TFs with novel regulatory roles in osteogenesis. We focused on the modules that were significantly enriched for DEGs and contained differentially expressed TFs that were identified as KNRs (Supplementary Table 4). We identified 80 such KNR TFs, of which 60 have unknown biological functions in osteogenesis (Supplementary Table 4). The top 3 up-regulated (<italic>HIF3A</italic>, <italic>ZBTB16</italic>, and <italic>NR2F1</italic>) (<xref ref-type="bibr" rid="c107">Zhu et al., 2014</xref>; <xref ref-type="bibr" rid="c65">Onizuka et al., 2016</xref>; <xref ref-type="bibr" rid="c56">Manikandan et al., 2018</xref>) and the top 2 down-regulated (<italic>TEAD4</italic>, <italic>HMGA1</italic>) (<xref ref-type="bibr" rid="c87">Suo et al., 2020</xref>; <xref ref-type="bibr" rid="c94">Wu et al., 2021</xref>) KNR TFs have established roles in osteogenesis. The third most down-regulated KNR TF is <italic>KLF16</italic> of Module M204, which previously had little known involvement in osteogenesis (Supplementary Table 4). Thus, based on our cumulative analyses, we hypothesized that <italic>KLF16</italic> plays an important role in osteogenic differentiation.</p>
<p>To further evaluate the expression patterns of the top candidate genes identified through our MEGENA, DEG, and TF-TF network analyses at the cell type level, we employed our previously published single-cell RNA-seq (scRNA-seq) data generated from iPSC-induced cells in osteogenic differentiation (<xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>). In that study, gene expression was assessed at two stages, MSCs (Day 0) and osteogenic cells (Day 21) – analogous to our MSC (Day 0) and OB (Day 21) stages for bulk RNA-seq, respectively. Although the differentiation culture conditions differed from this study, we found similar differential expression patterns in a pseudobulk analysis of the scRNA-seq time points for the top 5 gene sets of up- and down-regulated KNR TFs (Supplementary Table 4), TF regulators based on TF-TF regulatory networks (Supplementary Table 3), as well as 5 known osteogenic markers (<xref ref-type="fig" rid="figs3">Supplementary Figure 3</xref>; Supplementary Table 5). We further analyzed pseudobulk expression data derived from the five different osteogenic cell types at day 21 and found that most genes of interest showed similar levels of expression among these cell types with the most differences occurring in mature osteocytes, including a notable reduction of RUNX2 expression as expected (<xref ref-type="bibr" rid="c90">Thomas and Jaganathan, 2022</xref>) (Supplementary Table 6).</p>
</sec>
<sec id="s2e">
<title>Regulatory role of <italic>Klf16</italic> in murine osteogenic differentiation</title>
<p>We further focused on <italic>KLF16</italic>, as it is one of the top TFs in the TF regulatory network and a KNR in the co-expression network. <italic>KLF16</italic> is significantly downregulated from the MSC to the OB stage (<xref rid="fig5" ref-type="fig">Figure 5A</xref>), suggesting its inhibitory role in osteogenic differentiation. To validate this, we overexpressed <italic>Klf16</italic> in the murine preOB line MC3T3-E1 using lentiviral vector-mediated gene transfer (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). We then performed three independent osteogenic differentiation experiments, each with three technical replicates for each differentiation stage (Day 7, 14, and 21). Overexpression of <italic>Klf16</italic> in MC3T3-E1 cells dramatically suppressed osteogenic differentiation at the early stage (Day 7) with reduced ALP activity. At later stages (Day 14 and Day 21), reduced mineralization was detected by alizarin red and von Kossa staining in the <italic>Klf16</italic>-overexpressing cells compared to the control cells (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). The inhibitory effect of <italic>Klf16</italic> overexpression on osteogenic differentiation in vitro was observed consistently for each of the experimental and technical replicates.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Inhibitory role of <italic>Klf16</italic> in osteogenic differentiation in vitro and in vivo.</title>
<p><bold>(A)</bold> The expression of <italic>KLF16</italic> at three human osteogenic differentiation stages. Data are shown as mean + SEM. * MSC vs. preOB, # preOB vs. OB, or + MSC vs. OB, adjusted p value &lt; 0.001. <bold>(B)</bold> Analysis of <italic>Klf16</italic> expression by RT-qPCR in MC3T3-E1 cells transduced vectors containing either stuffer sequence or <italic>Klf16</italic> cDNA. Data are presented as the mean ± SEM (n=3, unpaired t-test p value &lt; 0.01) (Supplementary Table 7). <bold>(C)</bold> Osteogenic differentiation of MC3T3-E1 cells without or with overexpression of <italic>Klf16</italic>, stained for ALP at Day 7 and alizarin red and von Kossa at Day 14 and Day 21. <bold>(D)</bold> Length, fat mass, and lean mass of wild type (WT) and <italic>Klf16</italic><sup>+/-</sup> mice. <bold>(E)</bold> DEXA analysis of whole body (head excluded) bone mineral content (BMC), bone area (B-area), and bone mineral density (BMD) of WT and <italic>Klf16</italic><sup>+/-</sup> mice. <bold>(F)</bold> and <bold>(G)</bold> Representative microCT images of distal femur trabecular bone in <bold>(F)</bold> (<italic>left,</italic> top view; <italic>right</italic>, side view) and cortical bone in <bold>(G)</bold> from WT and <italic>Klf16</italic><sup>+/-</sup> mice. Scale bar: 1 mm. <bold>(H)</bold> and <bold>(I)</bold> Graphs show trabecular bone volume/tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) in <bold>(H)</bold>; cortical bone area (Ct.Ar), cortical periosteal perimeter (Ct.Pe.Pm), and cortical endosteal perimeter (Ct.En.Pm) in <bold>(I)</bold>. For <bold>(D)</bold>, <bold>(E)</bold>, <bold>(H)</bold>, and <bold>(I)</bold>, data are presented using BoxPlotR (<xref ref-type="bibr" rid="c84">Spitzer et al., 2014</xref>) as the mean ± SEM (WT n = 6, <italic>Klf16</italic><sup>+/-</sup> n = 6, 3 males and 3 females for each group, aged 17 weeks, paired t-test, n.s, not significant, * p value &lt; 0.05, ** p value &lt; 0.01).</p></caption>
<graphic xlink:href="579844v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To explore the role of <italic>Klf16</italic> in bone formation in vivo, we analyzed a <italic>Klf16</italic> knock-out mouse line, generated by deleting a 444 bp segment in exon one using CRISPR technology by the Knockout Mouse Phenotyping Program (KOMP). This mutation deletes the Kozak sequence and the ATG start codon, leaving the final 16 bp of exon one and the splice donor site. We examined adult wild type (WT) and heterozygous (<italic>Klf16<sup>+/-</sup></italic>) mice, excluding homozygous mice due to preweaning lethality. No significant difference in the overall length between adult <italic>Klf16<sup>+/-</sup></italic> mice and WT controls was found (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). However, adult <italic>Klf16</italic><sup>+/-</sup> mice had significantly increased lean mass (total tissue mass – fat mass, including bone mineral content) (p value &lt; 0.05), and no significant change in fat mass relative to WT mice (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). Furthermore, there was a dramatic increase in whole body bone mineral content (BMC), bone area, and bone mineral density in <italic>Klf16</italic><sup>+/-</sup> mice compared to WT control mice revealed by DEXA scanning (p value &lt; 0.01) (<xref rid="fig5" ref-type="fig">Figure 5E</xref>). Microcomputed tomography (microCT) scanning of trabecular bone from adult <italic>Klf16</italic><sup>+/-</sup> mice showed significantly increased bone volume fraction (BV/TV) (p value &lt; 0.05) and trabecular thickness (Tb.Th) (p value &lt; 0.01), and no significant difference in trabecular number (Tb.N) or trabecular separation (Tb.Sp) (<xref rid="fig5" ref-type="fig">Figure 5F</xref> and <xref rid="fig5" ref-type="fig">5H</xref>). In addition, adult <italic>Klf16</italic><sup>+/-</sup> mice showed significantly increased cortical bone area (Ct.Ar) (p value &lt; 0.05), cortical periosteal perimeter (Ct.Pe.Pm) (p value &lt; 0.01), and cortical endosteal perimeter (Ct.En.Pm) (p value &lt; 0.01) compared to WT control mice (<xref rid="fig5" ref-type="fig">Figure 5G</xref> and <xref rid="fig5" ref-type="fig">5I</xref>). These findings further support the inhibitory role of KLF16 in bone formation.</p>
<p>Given that bone phenotypes in vivo may be affected by both bone formation and resorption, we analyzed osteoclastogenesis in the <italic>Klf16</italic><sup>+/-</sup> mice. The expression of calcitonin receptor (CALCR) as a marker for osteoclasts (<xref ref-type="bibr" rid="c8">Boyce, 2013</xref>; <xref ref-type="bibr" rid="c64">Nicholson et al., 1986</xref>) was not significantly changed in the epiphysis of the femur, while increased expression was observed in the metaphysis of the <italic>Klf16</italic><sup>+/-</sup> mice compared to the controls (<xref ref-type="fig" rid="figs4">Supplementary Figure 4A</xref> and <xref ref-type="fig" rid="figs4">4B</xref>). In addition, we examined the expression of receptor activator of NF-kB ligand (RANKL), which binds to receptor activator of NF-kB (RANK) on the surface of osteoclast precursors, promoting their maturation into active osteoclasts and regulating osteoclastogenesis (<xref ref-type="bibr" rid="c37">Khosla, 2001</xref>; <xref ref-type="bibr" rid="c9">Boyle et al., 2003</xref>). In the femurs of the <italic>Klf16</italic><sup>+/-</sup> mice, the expression of RANKL did not show a significant change compared to control mice (<xref ref-type="fig" rid="figs4">Supplementary Figure 4C</xref> and <xref ref-type="fig" rid="figs4">4D</xref>). These results suggest that osteoclastogenesis is not decreased in the <italic>Klf16</italic><sup>+/-</sup> mice; therefore, increased bone mineral content and density in the mutant mice is more likely attributed to enhanced bone formation rather than reduced resorption by osteoclasts.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Understanding the cellular and molecular mechanisms underlying both normal and pathological bone formation requires insight into the global transcriptional changes during osteogenic differentiation. To investigate these changes, we utilized human iPSC-derived MSCs as our model system. By profiling RNA expression during in vitro osteogenic differentiation, we observed that the transcriptome profiles of our iPSC-derived MSCs and OBs were consistent with those of their primary counterparts, which suggests the potential applicability of our differentiation system to model in vivo osteogenesis. Our differential gene expression analyses provided insights into transcriptional signatures for each osteogenic stage, characterized by changes in expression levels of numerous coding and noncoding genes. Our systems biology approach revealed complex networks of TFs underlying osteogenic differentiation. TF networks in mammalian cells can be built by combining knowledge of TF binding events within TF genes and functional analysis (<xref ref-type="bibr" rid="c93">Wilkinson et al., 2017</xref>). Our research unveiled a multifaceted osteogenic differentiation TF network, segmented into five interactive modules. These modules, consistent with previous findings on functional modularity (<xref ref-type="bibr" rid="c18">Dittrich et al., 2008</xref>), showcased specific biological functions. For instance, Module 3 underscores TFs associated with fat cell differentiation, suggesting a balance between osteogenesis and adipogenesis within bone structures. This resonates with recent studies emphasizing the role of a network of stem cell TFs in osteogenesis, which act as repressors of adipogenesis (<xref ref-type="bibr" rid="c72">Rauch et al., 2019</xref>). Additionally, this module identifies TFs involved in muscle differentiation, indicating overlapping regulatory mechanisms for both bone and muscle development. This concept is further supported by recent discoveries linking mesenchymal progenitors in muscle to bone formation (<xref ref-type="bibr" rid="c34">Julien et al., 2021</xref>). This connectivity endorses known interactions between signaling pathways like TGF-β/BMP and Wnt (<xref ref-type="bibr" rid="c28">Hernández-Vega and Camacho-Arroyo, 2021</xref>; <xref ref-type="bibr" rid="c90">Thomas and Jaganathan, 2022</xref>). Overall, these findings reveal intricate TF regulatory networks and pathway interactions in osteogenic differentiation.</p>
<p>In addition, we explored the gene co-expression network, highlighting potential gene modules and key regulators that play an important role in differentiation. We experimentally validated the regulatory role of <italic>KLF16</italic> from Module M204 as a proof-of-concept that our dataset provides a resource for the discovery of novel mechanisms in osteogenic differentiation. Module M204 is enriched for DEGs, of which many are related to bone formation, including KNR genes <italic>PFN1</italic>, <italic>PHLDA2</italic>, and <italic>RHOC</italic>. We then focused on the KNR <italic>KLF16</italic>, which was not previously associated with bone formation, and investigated its involvement in osteogenic differentiation. Overexpression of <italic>Klf16</italic> in vitro reduced ALP activity and matrix mineralization during MC3T3-E1 differentiation. Conversely, heterozygous <italic>Klf16</italic> knockout mice showed altered bone characteristics, including increases in whole body BMD, femoral bone volume to total tissue volume, trabecular bone thickness, and cortical bone area, suggesting KLF16’s regulatory function in inhibiting osteogenic differentiation.</p>
<p>KLF16, a C2H2-type zinc finger transcription factor, has affinity for GC and GT boxes, and displaces TFs SP1 and SP3 in neural settings (<xref ref-type="bibr" rid="c32">Hwang et al., 2001</xref>; <xref ref-type="bibr" rid="c92">Wang et al., 2016</xref>). These TFs, when attached to certain promoters, play roles in osteogenic differentiation (<xref ref-type="bibr" rid="c45">Le Mée et al., 2005</xref>). Furthermore, KLF16 targets specific metabolic genes, including estrogen-related receptor beta (ESRRB) and PPARA (<xref ref-type="bibr" rid="c15">Daftary et al., 2012</xref>; <xref ref-type="bibr" rid="c86">Sun et al., 2021</xref>). Our TF regulatory network analysis indicates that <italic>KLF16</italic> is associated with Notch signaling and TGFβ/BMP-SMAD signaling pathways, and regulation of ncRNA transcription. This paints a broad canvas of potential regulatory mechanisms for KLF16 in bone dynamics. Furthermore, other members from the KLF family, especially <italic>KLF4</italic> (Module 1), <italic>KLF5</italic> (Module 5), and <italic>KLF15</italic> (Module 3) (Supplementary Table 4), significantly influence skeletal development (<xref ref-type="bibr" rid="c80">Shinoda et al., 2008</xref>; <xref ref-type="bibr" rid="c82">Song et al., 2017</xref>; <xref ref-type="bibr" rid="c49">Li et al., 2021</xref>; <xref ref-type="bibr" rid="c100">Yu et al., 2021</xref>; <xref ref-type="bibr" rid="c101">Zakeri et al., 2022</xref>). <italic>KLF5</italic>, co-existing with <italic>KLF16</italic> in Module 5, curtails osteogenesis by inhibiting β-catenin through DNMT3B-induced hypermethylation (<xref ref-type="bibr" rid="c49">Li et al., 2021</xref>). KLF4’s modulation of osteogenic differentiation hinges on the BMP4-dependent pathway, resulting in reduced osteoblast numbers in the deficient mice (<xref ref-type="bibr" rid="c100">Yu et al., 2021</xref>). Meanwhile, KLF15 enhances chondrogenic differentiation via the TF SOX9 promoter (<xref ref-type="bibr" rid="c82">Song et al., 2017</xref>). The roles of KLF6 and KLF9 (Modules 3 and 2) in bone formation remain less defined (<xref ref-type="bibr" rid="c101">Zakeri et al., 2022</xref>). Collectively, these findings underline the KLF family’s complex involvement in osteogenesis.</p>
<p>Interestingly, <italic>KLF16</italic> was upregulated in the MSCs of elderly patients suffering from osteoporosis compared to age-matched controls in a previous study (<xref ref-type="bibr" rid="c6">Benisch et al., 2012</xref>). A following study identified KLF16 as one of the key TFs whose targets were enriched from the DEGs in the MSCs of the osteoporosis patients versus controls (<xref ref-type="bibr" rid="c54">Liu et al., 2019</xref>). The inhibitory role of KLF16 in osteogenic differentiation identified in our study supports the hypothesis that the overexpression of <italic>KLF16</italic> might contribute to osteoporosis, and that KLF16 could therefore be a potential therapeutic target.</p>
<p>Taken together, the differentiation of iPSC-derived MSCs to OBs provides a valuable model for investigating gene expression and regulatory networks in osteogenic differentiation. Our study sheds light on the intricate, layered, and dynamic regulation of the transcriptomic landscape in osteogenic differentiation and offers a foundational resource for further exploration of normal bone formation and the mechanisms driving pathological conditions. Furthermore, this experimental model might facilitate therapeutic research, with potential applications in the treatment of conditions such as osteoporosis.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Human subjects</title>
<p>The twenty human subjects included in this study were in good general health. The study protocols and informed consent were approved by the Institutional Review Board (IRB) of Stanford University and the IRB of the Icahn School of Medicine at Mount Sinai. Each subject gave written informed consent for study participation. Complete subject demographic data can be found in Supplementary Table 1.</p>
</sec>
<sec id="s4b">
<title>Animal care and use</title>
<p>The <italic>Klf16</italic><sup>+/-</sup> mouse strain C57BL/6NJ-Klf16em1(IMPC)J/Mmjax was generated on the C57BL/6NJ genetic background by the Knockout Mouse Phenotyping Program (KOMP) at The Jackson Laboratory (Stock# 032653) using CRISPR technology. Procedures using mice were in compliance with animal welfare guidelines mandated by the Institutional Animal Care and Use Committee (IACUC) and Institutional Biosafety Committee (IBC) at The Jackson Laboratory. Genotyping was performed by real-time PCR of DNA extracted from tail biopsies. A detailed protocol can be found on The Jackson Laboratory website.</p>
</sec>
<sec id="s4c">
<title>Cell lines</title>
<p>MC3T3-E1 Subclone 4 cell line was purchased from ATCC (CRL-2593, sex undetermined). Irradiated mouse embryonic fibroblasts (MEFs) were purchased from GlobalStem (GSC-6001G). Human iPSC lines were generated in this study. The cells were maintained at 37°C with 5% CO2.</p>
</sec>
<sec id="s4d">
<title>Peripheral blood mononuclear cell (PBMC) and dermal fibroblast isolation</title>
<p>PBMCs were isolated as we previously described (<xref ref-type="bibr" rid="c12">Carcamo-Orive et al., 2017</xref>). Briefly, blood was drawn in tubes containing sodium citrate anticoagulant solution (BD Vacutainer CPT mononuclear cell preparation tube, 362760). PBMCs were separated by gradient centrifugation. The cells were then frozen in RPMI medium (MilliporeSigma, R7388) supplemented with either 12.5% human serum albumin and 10% DMSO (MilliporeSigma, D2438) or 10% fetal bovine serum (FBS) (MilliporeSigma, F4135) and 10% DMSO, and stored in liquid nitrogen for later use. The detailed protocol for dermal fibroblast isolation can be found in our previous publication (<xref ref-type="bibr" rid="c76">Schaniel et al., 2021</xref>). Briefly, a skin sample was taken from each of the clinically healthy subjects using a 3 mm sterile disposable biopsy punch (Integra Miltex, 98PUN3-11). Each sample was cut into smaller pieces and placed into gelatin-coated tissue culture dishes with DMEM (Thermo Fisher Scientific, 10567022) supplemented with antibiotics, 20% FBS, non-essential amino acids (Thermo Fisher Scientific, 11140050), 2mM L-glutamine (Thermo Fisher Scientific, 25030081), 2 mM sodium pyruvate (Thermo Fisher Scientific, 11360070), and 100 μM 2-mercaptoethanol (MP Biomedicals, C194705) to establish fibroblast lines. Fibroblasts were harvested using TrypLE Express (Thermo Fisher Scientific, 12605010) and passaged at a 1 to 4 split ratio. Fibroblasts were cryopreserved in 40% DMEM, 50% FBS, and 10% DMSO.</p>
</sec>
<sec id="s4e">
<title>iPSC generation</title>
<p>Erythroblast protocol: The detailed erythroblast reprogramming process can be found in our previous publication (<xref ref-type="bibr" rid="c12">Carcamo-Orive et al., 2017</xref>). Briefly, PBMCs were thawed, and the erythroblast population was expanded for 9–12 days until approximately 90% of cells expressed CD36 and CD71. These expanded erythroblasts were reprogrammed by transduction with Sendai viruses (SeV) expressing factors OCT3/4, SOX2, KLF4, and c-MYC using the CytoTune™-iPS 2.0 Sendai Reprogramming kit (Thermo Fisher Scientific, A16518) according to manufacturer’s protocol.</p>
<p>Fibroblast protocol: The detailed fibroblast reprogramming process can be found in our previous publication (<xref ref-type="bibr" rid="c76">Schaniel et al., 2021</xref>). Briefly, mycoplasma-free fibroblasts at passage number 3-5 were reprogrammed using the mRNA reprogramming Kit (Stemgent, 00-0071) in combination with the microRNA booster kit (Stemgent, 00-0073) according to the manufacturer’s protocol.</p>
</sec>
<sec id="s4f">
<title>iPSCs expansion and characterization</title>
<p>To establish iPSCs, the cells were cultured on Matrigel (BD Bioscience, 354230-10, or Corning, 254248) in feeder-free conditions and maintained in mTeSR1 (Stem Cell Technologies, 05850). The iPSCs were passaged every 5-7 days after clones were picked. To ensure the high quality of the iPSC lines used in this study, those lines generated with Sendai virus first underwent virus clearance by continuous passaging. To measure the loss of SeV in the iPSCs generated from erythroblasts with SeV, quantitative RT-PCR was performed according to the SeV reprogramming kit manufacture protocol. For quality control, G-banded karyotyping, ALP staining, iPSC pluripotency marker immunocytochemistry, and embryoid body formation analysis (<xref ref-type="bibr" rid="c95">Yaffe et al., 2016</xref>) were performed. Differentiating colonies were routinely eliminated from the cultures. All the lines included in the current study had normal karyotypes, exhibited human embryonic stem cell morphology, and expression of ALP and pluripotency markers NANOG, SOX2, OCT4, SSEA4, and TRA-1-60. Further, embryoid body (EB) formation and differentiation assays demonstrated their competence for differentiation into all three germ layers. We excluded samples where any of these characterizations were abnormal (<xref ref-type="bibr" rid="c16">Daley et al., 2009</xref>; <xref ref-type="bibr" rid="c95">Yaffe et al., 2016</xref>).</p>
</sec>
<sec id="s4g">
<title>Mycoplasma quality control</title>
<p>Mycoplasma testing of the cells was performed intermittently during culture. Cultures were grown in the absence of antibiotics for at least three days before testing. The culture medium or the DNA harvested from the cultures were tested for mycoplasma contamination using a MycoAlert Mycoplasma Detection Kit (Lonza, LT07-418) or e-Myco PLUS PCR Detection Kit (BOCA scientific, 25237).</p>
</sec>
<sec id="s4h">
<title>ALP staining</title>
<p>Cells cultured on plates were briefly washed with phosphate-buffered saline (PBS), fixed in 4% PFA for 3 minutes at room temperature, and then stained with Alkaline phosphatase kit II (Stemgent, 00-0055) according to the manufacturer’s instructions.</p>
</sec>
<sec id="s4i">
<title>iPSC embryoid body analysis</title>
<p>iPSC embryoid body formation and characterization were performed as previously described with modifications (<xref ref-type="bibr" rid="c52">Lin and Chen, 2008</xref>). Briefly, iPSCs were cultured in mTeSR1 medium on Matrigel-coated plates, and the medium was changed daily. On the day of EB formation, when the cells grew to 60-80% confluence, cells were washed once with PBS and then incubated in Accutase for 8-10 minutes to dissociate colonies to single cells and resuspended with mTeSR1 containing 2 µM Thiazovivin. To form self-aggregated EBs, single iPSCs were transferred into an ultra-low attachment plate (Corning, CLS3471) via 1:1 or 1:2 passage. EBs were aggregated from iPSCs for three days, then were transferred to 0.1% gelatin-coated 12 well plates and maintained in embryoid body medium (DMEM/F12 supplemented with 10% FBS, 2 mM L-glutamine, 0.1 mM non-essential amino acids, and 0.1 mM 2–mercaptoethanol) for another ten days for the spontaneous generation of three germ layers with medium changed every other day. Fluorescent immunostaining was performed to detect the expression of markers of the three germ layers.</p>
</sec>
<sec id="s4j">
<title>Fluorescence immunocytochemistry</title>
<p>The cells cultured on plates were briefly washed with PBS, fixed in 4% paraformaldehyde (PFA) in PBS for 15 minutes, washed with PBS three times, and then permeabilized with 0.2% Triton in PBS for 15 mins. The cells were then washed with PBS three times prior to blocking with 1% bovine serum albumin (BSA) (MilliporeSigma, A8412) in PBS for 1 hour at room temperature and incubating with primary antibody 1:100 to 1:900 dilutions in 0.1% BSA in PBS for overnight at 4°C. Washing three times was conducted with PBS followed by incubation with a corresponding secondary antibody in 1:500 dilution in 0.1% BSA for 1 hour at room temperature. After washing with PBS, 1:50,000 diluted Hoechst (Thermo Fisher Scientific, H1398) was added to stain nuclei for 5 minutes, followed by washing with PBS three times and imaging. The following primary antibodies were applied to detect the expression of iPSC markers: anti-TRA-1-60 (Invitrogen, 41-1000, 1/100), anti-SSEA4 (Invitrogen, 41-4000, 1/200), anti-NANOG (Abcam, ab109250, 1/100), anti-OCT-4 (Cell Signaling Technology, 2840S, 1/400), and anti-SOX2 (Abcam, ab97959, 1/900). To detect the expression of the markers of three germ layers, anti-AFP (Agilent, A0008, 1/100) for endoderm, anti-α-SMA (MilliporeSigma, A5228, 1/200) for mesoderm, and anti-TUBB3 (MilliporeSigma, T2200, 1/200) for ectoderm were used. All the Alexa-conjugated secondary antibodies used were from Invitrogen: anti-mouse Alexa Fluor 488 (A-11029), anti-rabbit Alexa 488 (A-21206), and anti-rabbit Alexa 594 (A-11037).</p>
</sec>
<sec id="s4k">
<title>G-banding karyotyping</title>
<p>Karyotype analysis was performed on all iPSC lines by the Human Genetics Core facility at SEMA4. iPSCs were cultured on Matrigel-coated T25 flasks before karyotyping and reached approximately 50% confluence on the day of culture harvest for karyotyping. Twenty cells in metaphase were randomly chosen, and karyotypes were analyzed using the CytoVision software program (Version 3.92 Build 7, Applied Imaging).</p>
</sec>
<sec id="s4l">
<title>Differentiation of iPSCs to MSCs</title>
<p>In vitro differentiation of iPSCs to MSCs was carried out with commercial cell culture media according to the manufacture protocols with modifications. Briefly, iPSC colonies were harvested with Accutase (Innovative Cell Technologies, AT-104) and seeded as single cells on a Matrigel-coated plate in mTeSR1 and supplemented with 2uM Thiazovivin. The next day, TeSR1 medium was replaced with STEMdiff mesoderm induction medium (MIM) (Stem Cell Technologies, 05221) when cells were at approximately 20-50% confluence. Cells were then fed daily and cultured in STEMdiff MIM for four days. On Day 5, the culture medium was switched to MesenCult-ACF medium (Stem Cell Technologies, 05440/8) for the rest of the MSC induction duration. Cells were passaged as necessary using MesenCult-ACF Dissociation Kit (Stem Cell Technologies, 05426). Cells were subcultured onto Matrigel at the first passage to avoid loss of the differentiated cells before tolerating the switch to MesenCult-ACF attachment substrate (Stem Cell Technologies, 05448). For passage two or above, cells were subcultured on MesenCult-ACF attachment substrate. After three weeks of differentiation, the cells were sorted for the CD105 (BD Biosciences, 561443, 1/20) positive and CD45 (BD Biosciences, 555483, 1/5) negative MSC population (<xref ref-type="bibr" rid="c24">Giuliani et al., 2011</xref>; <xref ref-type="bibr" rid="c36">Kang et al., 2015</xref>; <xref ref-type="bibr" rid="c83">Sotiropoulou et al., 2006</xref>) using BD FACSAria II in the Mount Sinai Flow Cytometry Core Facility, and then expanded in MSC medium consisting of low-glucose DMEM (Gibco, 10567022) containing 10% FBS (<xref ref-type="bibr" rid="c83">Sotiropoulou et al., 2006</xref>). After expansion, a few MSC lines were further examined by BD CantoII for expression of other MSC positive surface markers CD29 (Thermo Fisher Scientific, 17– 0299, 1/20), CD73 (BD Biosciences, 561254, 1/20), CD90 (BD Biosciences, 555595,1/ 20), absence of other negative surface markers CD31 (BD Biosciences, 561653, 1/20), CD34 (BD Biosciences, 560940, 1/5), and retention of marker CD105 positivity and CD45 negativity as well.</p>
</sec>
<sec id="s4m">
<title>Fluorescence activated cell sorting (FACS) and analysis</title>
<p>Single cells were washed with FACS buffer (PBS supplemented with 1% FBS and 25mM HEPES (Thermo Fisher Scientific, 1688449)) twice, resuspended to a concentration of 1X10<sup>7</sup> cells/ml in ice-cold FACS buffer, and incubated with the above conjugated antibodies for 30 minutes at 4° in the dark. Stained cells were then washed with FACS buffer three times before FACS or flow cytometry analysis. Flow cytometry data were analyzed with BD FACSDiva software.</p>
</sec>
<sec id="s4n">
<title>Differentiation of iPSC-derived MSCs to osteoblasts</title>
<p>iPSC-derived MSCs were plated in a 6-well plate at a density of 3X10<sup>3</sup> cells/cm<sup>2</sup> in MSC medium. After three days, the culture medium was switched to osteogenic differentiation medium (α MEM (Thermo Fisher Scientific, A1049001) supplemented with 10% FBS, 1% non-essential amino acids, 0.1 µM dexamethasone (MilliporeSigma, D4902), 10 mM β-glycerophosphate (MilliporeSigma, G9422), and 200 µM ascorbic acid (MilliporeSigma, A4544)) and maintained in this medium for 21 days (<xref ref-type="bibr" rid="c4">Barberi et al., 2005</xref>; <xref ref-type="bibr" rid="c46">Lee et al., 2015</xref>; <xref ref-type="bibr" rid="c69">Pittenger et al., 1999</xref>). The culture medium was changed every 2-3 days. Cells were harvested for total RNA isolation and RNA sequencing at Day 0, Day 7, and Day 21 of differentiation, as indicated in the main text. ALP staining, and alizarin red staining and von Kossa staining, were employed to examine bone ALP expression and mineralization, respectively.</p>
</sec>
<sec id="s4o">
<title>Alizarin red staining and von Kossa staining</title>
<p>Mineralization of osteoblast extracellular matrix was assessed by both alizarin red staining and von Kossa staining. Cells were washed briefly with PBS, fixed with 4% PFA for 15 minutes, and washed with deionized distilled water three times. For alizarin red staining, fixed cells were incubated in alizarin red stain solution (MilliporeSigma, TMS-008-C) with gentle shaking for 30 minutes, followed by washing with water four times for 5 minutes each with gentle shaking to remove non-specific alizarin red staining. For von Kossa staining, fixed cells were incubated in 5% silver nitrate solution (American Master Tech Scientific, NC9239431) while exposed to UV light for 20 minutes. Unreacted silver was removed by incubating in 5% sodium thiosulfate (American Master Tech Scientific, NC9239431) for 5 minutes, followed by washing with water twice. Mineralized nodules were identified as red spots by alizarin red staining and dark brown to black spots by von Kossa staining.</p>
</sec>
<sec id="s4p">
<title>RNA-seq library preparation and sequencing</title>
<p>For total RNA isolation, cells were washed with PBS and harvested for RNA extraction using miRNeasy mini kit (QIAGEN, 217004) according to the manufacturer’s instruction. Illumina library preparation and sequencing were conducted by the Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine (Baltimore, MD). RNA concentration and quality were determined using NanoDrop Spectrophotometer (Thermo Scientific, DE). RNA integrity (RNA Integrity Number, RIN) was verified using Agilent BioAnalyzer 2100 and the RNA Nano Kit prior to library creation. Illumina’s TruSeq Stranded Sample Prep kit was used to generate libraries. Specifically, after ribosomal RNA (rRNA) depletion, RNA was converted to cDNA and size selected to 150-200 bp in length, then end-repaired and ligated with appropriate adaptors. Ligated fragments were subsequently size-selected and underwent PCR amplification techniques to prepare the libraries with a median size of 150 bp. Libraries were uniquely barcoded and pooled for sequencing. The BioAnalyzer was used for quality control of the libraries to ensure adequate concentration and appropriate fragment size. Sequencing was performed on an Illumina HiSeq 2500 instrument using standard protocols for paired-end 100 bp sequencing. All the samples were processed in one batch.</p>
</sec>
<sec id="s4q">
<title>RNA-seq pre-processing and gene differential expression analyses</title>
<p>Illumina HiSeq reads were processed through Illumina’s Real-Time Analysis (RTA) software generating base calls and corresponding base call quality scores. CIDRSeqSuite 7.1.0 was used to convert compressed bcl files into compressed fastq files. After adaptor removal with cutadapt (<xref ref-type="bibr" rid="c57">Martin, 2011</xref>) and base quality trimming to remove 3′ read sequences if more than 20 bases with Q ≥ 20 were present, paired-end reads were mapped to the human GENCODE V29 reference genome using STAR (<xref ref-type="bibr" rid="c19">Dobin et al., 2013</xref>) and gene count summaries were generated using featureCounts (<xref ref-type="bibr" rid="c51">Liao et al., 2014</xref>). Raw fragment (i.e., paired-end read) counts were then combined into a numeric matrix, with genes in rows and experiments in columns, and used as input for differential gene expression analysis with the Bioconductor Limma package (<xref ref-type="bibr" rid="c73">Ritchie et al., 2015</xref>) after multiple filtering steps to remove low-expressed genes. First, gene counts were converted to FPKM (fragments per kb per million reads) using the RSEM package (<xref ref-type="bibr" rid="c48">Li and Dewey, 2011</xref>) with default settings in strand-specific mode, and only genes with expression levels above 0.1 FPKM in at least 20% of samples were retained for further analysis. Additional filtering removed genes less than 200 nucleotides in length. Finally, normalization factors were computed on the filtered data matrix using the weighted trimmed mean of M values (TMM) method, followed by voom (<xref ref-type="bibr" rid="c44">Law et al., 2014</xref>) mean-variance transformation in preparation for Limma linear modeling. The limma generalized linear model contained fixed effects for sex (male/female), and cell source (fibroblast/erythroblast) and a random effect term was included for each unique subject. Data were fitted to a design matrix containing all sample groups, and pairwise comparisons were performed between sample groups (i.e., MSC stage, preOB stage, and OB stage). eBayes adjusted p values were corrected for multiple testing using the Benjamin-Hochberg (BH) method (Benajmin and Hochberg, 1995) and used to select genes with significant expression differences (adjusted p value &lt; 0.05).</p>
</sec>
<sec id="s4r">
<title>Integration of RNA-Seq data of human primary MSCs and OBs, iPSCs, and tissues in GTEx</title>
<p>GTEx gene expression data (version 7) and metadata were downloaded from the GTEx website (<xref ref-type="bibr" rid="c2">Ardlie et al., 2015</xref>). Raw counts were extracted for the brain, heart, kidney, liver, lung, muscle, nerve, ovary, testis, and thyroid tissues. After filtering the lowly expressed genes (1 CPM in less than 20% samples), normalization factors were computed using the weighted trimmed mean of M values (TMM) method, followed by the voom mean-variance transformation (<xref ref-type="bibr" rid="c44">Law et al., 2014</xref>). The Human iPSC dataset was from our previous publication, deposited in the GEO database with accession number GSE79636 (<xref ref-type="bibr" rid="c12">Carcamo-Orive et al., 2017</xref>). Two datasets for each primary human MSC and OB cell type were collected from the GEO accessions GSE94736 (<xref ref-type="bibr" rid="c74">Roforth et al., 2015</xref>) and GSE118808 (<xref ref-type="bibr" rid="c35">Kaczynski et al., 2003</xref>; <xref ref-type="bibr" rid="c55">Ma et al., 2019</xref>), and GSE55282 (<xref ref-type="bibr" rid="c75">Rojas-Peña et al., 2014</xref>) and GSE75524 (<xref ref-type="bibr" rid="c1">Al-Rekabi et al., 2016</xref>), respectively. All the datasets were filtered and normalized in the same way as the GTEx data. Genes from all the datasets were intersected to obtain shared genes. Gene expression levels of the shared genes were extracted from all the datasets. Principal component analysis (PCA) was performed on the extracted and combined gene expression matrix. Multi-dimensional scaling was used to visualize the top two principal components.</p>
</sec>
<sec id="s4s">
<title>Gene ontology and Reactome pathway enrichment analyses</title>
<p>Gene ontology (GO) biological process (BP), molecular function (MF), and cellular component (CC), and Reactome pathway enrichment analyses were performed using the PANTHER classification system (<ext-link ext-link-type="uri" xlink:href="https://www.pantherdb.org">www.pantherdb.org</ext-link>) (<xref ref-type="bibr" rid="c59">Mi et al., 2019a</xref>). The statistical overrepresentation test in PANTHER was fulfilled by Fisher’s exact test together with FDR multiple test correction to identify enriched GO categories and Reactome Pathways among the input genes relative to the indicated reference list as stated in figure legends (<xref ref-type="bibr" rid="c89">The Gene Ontology Consortium, 2019</xref>; <xref ref-type="bibr" rid="c60">Mi et al., 2019b</xref>). Enrichment tests were filtered using FDR &lt; 0.05.</p>
</sec>
<sec id="s4t">
<title>Transcription factor network analysis</title>
<p>The ChIP-seq and ChIP-exo datasets of DNA binding peaks of human transcription regulators (TRs), where the overwhelming majority are TFs, were downloaded from ReMap 2020 (<xref ref-type="bibr" rid="c14">Chèneby et al., 2020</xref>). The genomic coordinates of the transcription start sites of human genes were extracted from Ensembl Human Genes GRCh37.p13, and then applied BedTools v2.3.0 to identify the target TR genes of a TR by checking the intersection of the latter TR’s binding peaks and the 2kb window before and after the transcription start sites of the target TR genes (<xref ref-type="bibr" rid="c71">Quinlan and Hall, 2010</xref>). The Python package scipy.stats.pearsonr was used to calculate the correlation coefficient between the expression of TR genes (<xref ref-type="bibr" rid="c27">Hao et al., 2015</xref>; <xref ref-type="bibr" rid="c33">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="c91">Virtanen et al., 2020</xref>; <xref ref-type="bibr" rid="c106">Zhu et al., 2015</xref>). The regulatory relationship between TRs was predicted using two criteria: (1) the binding site peaks of a TR are within the distance of 2 kb upstream or downstream of the known transcription start sites of the target TRs; and (2) the absolute value of the correlation coefficient between the TR genes is greater than 0.6 and adjusted p value is less than 0.05 (<xref ref-type="bibr" rid="c11">Camacho et al., 2005</xref>). Gephi 0.9.2 was used to generate and visualize the regulatory network, where each node was defined as a TR gene, and two nodes were connected by an edge when ReMap data demonstrated regulation between the two TRs, and our RNA-seq data also showed expression correlation between them. Furthermore, the network community detection hierarchical algorithm was applied to determine relationships between subsets of the whole network and define modules. Betweenness centrality for each of the nodes was calculated and then used to rank node sizes (<xref ref-type="bibr" rid="c5">Bastian et al., 2009</xref>).</p>
</sec>
<sec id="s4u">
<title>Gene co-expression network analysis and identification of key network regulators</title>
<p>Gene co-expression network was constructed using the R package MEGENA v1.3.7 (<xref ref-type="bibr" rid="c81">Song and Zhang, 2015</xref>). The same filtered, normalized, and covariate-adjusted gene expression data matrix used in the differential gene expression analysis was used as input for MEGENA. Specifically, the Pearson correlation was used to calculate significant correlations between gene pairs among the 60 samples. With a cutoff of 0.05 FDR, significant correlations were identified by 100 permutations of the gene expression matrix. Next, planar-filtered network construction and multi-scale clustering analysis were performed. Finally, significant modules were identified at a 5% FDR with 100 times network permutations. Modules of smaller than 50 genes or larger than 5,000 genes were excluded from the downstream analyses. Enrichment analysis was performed between the modules and DEG signatures between MSC and preOB stages and between preOB and OB stages through Fisher’s exact test. BH procedure was applied to the p values to correct for multiple-testing problem (<xref ref-type="bibr" rid="c7">Benjamini and Hochberg, 1995</xref>). Modules were visualized using the Cytoscape (<xref ref-type="bibr" rid="c66">Otasek et al., 2019</xref>). Sunburst plots of modules were visualized using the R package <italic>sunburstR</italic> v2.1.5. We used all the MEGENA nodes and edges as input to identify KNRs that were predicted to modulate a large number of downstream DEGs in the network (<xref ref-type="bibr" rid="c102">Zhang et al., 2013</xref>; <xref ref-type="bibr" rid="c103">Zhang and Zhu, 2013</xref>). For each gene in the MEGENA network, we tested whether the network neighborhood of the gene was enriched with the DEG signature. Specifically, we tested if the nodes within a path length of 6 steps of the candidate KNR gene were enriched for the DEGs using Fisher’s Exact test. The p values were then corrected by the Bonferroni procedure to adjust for multiple comparisons.</p>
</sec>
<sec id="s4v">
<title>Processing of comparative single-cell pseudobulk data</title>
<p>scRNA-seq data (GEO accession: GSE181744) from our previous publication (<xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>), which includes mixtures of iPSC-derived, MSC osteogenic differentiations from different species, was used as a comparative dataset. To maximize the comparative utility of these data, we re-processed the raw scRNA-seq data to obtain pseudobulk expression values for all genes annotated in the human genome and for cell types of interest from the six humans and one human technical replicate included in this dataset. Briefly, reads were processed using standard 10X Genomics Cell Ranger 3.1.0 pipelines (<xref ref-type="bibr" rid="c104">Zheng et al., 2017</xref>) that extracted 10X cell barcodes and UMIs and aligned the remaining reads to the human genome (hg38). Human cells and specific cell types of interest (MSCs, osteogenic cells, preosteoblasts, osteoblasts, embedding osteoblasts, mineralizing osteoblasts, and maturing osteocytes) were isolated from the newly processed data using species assignments and cell classifications (<xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>). Lastly, single-cell gene count data were consolidated to produce pseudobulk expression values for each unique grouping of individual, replicate, and cell classification. Specifically, these pseudobulk data were defined as the sum of raw single-cell UMI counts within each individual-replicate for a given cell classification. Computational scripts for these processing steps can be found on GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/ghousman/human-skeletal-scRNA">https://github.com/ghousman/human-skeletal-scRNA</ext-link>. Pseudobulk data were filtered and normalized as described above.</p>
</sec>
<sec id="s4w">
<title>Generation of <italic>Klf16</italic>-overexpressed MC3T3-E1 cell line</title>
<p>Lentiviral transduction of MC3T3-E1 Subclone 4 cells (ATCC, CRL-2593) was performed as we previously described with modifications (<xref ref-type="bibr" rid="c29">Holmes et al., 2020</xref>). Cells were infected by incubating in lentivirus-containing cell culture medium at a multiplicity of infection (MOI) of 100 in the presence of 6 μg/ml polybrene for 24 hours. The selection was performed with 2 µg/ml puromycin for 12 days until EGFP expression was observed in 100% of cells, no further cell death was observed, and no live cells remained in the non-transduction negative control dish. Selected cells were expanded and cryopreserved. EGFP expression was monitored routinely, and additional selection was performed when necessary.</p>
</sec>
<sec id="s4x">
<title>MC3T3-E1 osteoblast differentiation assay</title>
<p>Osteoblast differentiation of MC3T3-E1 transfected with lentiviral vectors containing either <italic>Klf16</italic> cDNA or a 300bp nonfunctional stuffer sequence was performed as follows: cells were plated in 6-well plates at a density of 3X10<sup>3</sup> cells/cm<sup>2</sup> in MC3T3-E1 maintenance medium (αMEM supplemented with 10% FBS). After three days, the culture medium was switched to osteogenic differentiation medium (<xref ref-type="bibr" rid="c29">Holmes et al., 2020</xref>), and cells were maintained in this medium, which was replenished every two days for 21 days. Triplicate experiments, each having triplicate wells, were carried out for both control and <italic>Klf16</italic>-overexpressing cells.</p>
</sec>
<sec id="s4y">
<title>RT-qPCR</title>
<p>The RT-qPCR method was used to assess gene expression in stable lentiviral MC3T3-E1 cell lines. When cells were plated in 6 well plates for osteogenic differentiation as described above, one parallel well was used for RNA isolation after being cultured in MC3T3-E1 maintenance medium for three days before switching to osteogenic differentiation medium. Total RNA was extracted with the RNeasy Kit (Qiagen, 74106) according to the manufacturer’s protocol. cDNA was synthesized with AffinityScript One-Step RT-PCR Kit (Agilent, 600188). Each cDNA sample was amplified in triplicate using the SYBR Green and Platinum Taq polymerase (Thermo Fisher Scientific, S7567) on a 7900HT Real-Time PCR instrument (Thermo Fisher Scientific, 10966). The housekeeping gene <italic>Actb</italic> was used as the reference. mRNA relative expression was calculated by the ΔΔCt method. qPCR primers used are listed in Supplementary Table 7.</p>
</sec>
<sec id="s4z">
<title>Whole body bone mineral density</title>
<p>Bone mineral density (BMD) was scanned with a Dual Energy X-ray Absorptiometry (DEXA) Analyzer (Lunar, Piximus II, GE Medical System). Mouse weight and length were measured (nose to the beginning of tail) before scanning. Each unconscious mouse was placed in the DEXA analyzer. A scout-scan was performed. The analysis was conducted on a whole body scan, excluding the head. The mouse was removed once the image was captured and placed on a heated mat set at 37°C in a cage and closely monitored until consciousness was regained.</p>
</sec>
<sec id="s4aa">
<title>Microcomputed tomography</title>
<p>Femurs were isolated by removing attached soft tissues, fixed in 4% PFA at 4°C, and imaged with microCT scan (Skyscan 1172a, Skyscan, Belgium) at 50 kV and 200 µA using a 0.5 mm aluminum filter and an image voxel size of 4.5 µm isotropic. Images were captured every 0.7°, with 8× averaging, through 180° rotation of each bone and reconstructed using Skyscan NRecon software. Imaging analysis of the metaphyseal regions of each femur was performed by first determining a reference point of the most proximal slice where the growth plate had begun to disappear. Offsets of 101 slices and 501 slices from the point of reference in the growth plate were used for trabecular and cortical analyses, respectively, with Skyscan CTAn software. Volume visualization was performed in Avizo 2020.2 (Thermo Fisher Scientific). Data were reported in the standard format used by the American Society for Bone and Mineral Research (ASBMR) (<xref ref-type="bibr" rid="c68">Parfitt et al., 1987</xref>). Each volume was then segmented to isolate osteological material using a regularized deep network (RDN)-based image segmentation algorithm (<xref ref-type="bibr" rid="c98">Yazdani et al., 2020</xref>). The segmented images were thresholded and masked in Medtool 4.4 (DPI e.U, Medtool) to isolate trabecular bone from cortical bone (<xref ref-type="bibr" rid="c25">Gross et al., 2014</xref>). The external mask (cortical bone) was subtracted from the volume, leaving only the internal mask (trabecular bone) and air. Bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) were calculated from the trabecular bone volumes in 3D using 7 mm sampling spheres on a background grid with 3.5 mm spacing following <xref ref-type="bibr" rid="c17">DeMars et al. (2021)</xref> in Medtool. Cortical bone variables cortical area (Ct.Ar), cortical periosteal perimeter (Ct.Pe.Pm), and cortical endosteal perimeter (Ct.En.Pm) were then calculated in the BoneJ extension of ImageJ (<xref ref-type="bibr" rid="c20">Doube et al., 2010</xref>) for each volume.</p>
</sec>
<sec id="s4ab">
<title>Immunohistochemistry</title>
<p>Femurs from two male <italic>Klf16<sup>+/-</sup></italic> mice and two male WT mice at the age of 18 weeks were fixed and prepared for paraffin section. Sections were deparaffinized in xylene and rehydrated through a gradient of ethanol (100%, 95%, and 70%, 5 minutes each) to water. Slides were incubated in 0.2% Triton X-100 for 5 min. After washing in PBS, endogenous fluorescence was blocked using TrueBlack Plus Lipofuscin Autofluorescence Quencher (1:40, Biotium, 23014) for 20 min, and then blocked with an Animal-Free Blocker (Vector Laboratories, SP-5035-100) for 1 hour at RT. The primary antibody anti-CALCR (1:50, Bioss, BS-0124R), or anti-RANKL (1:50, Abcam, ab216484), was applied and incubated overnight at 4°C. After washing in PBS, secondary antibody (Alexa Fluor 488 chicken anti-Rabbit IgG, 1:500, Invitrogen, A-21441) was applied and incubated for 1 hour at room temperature. Slides were then washed in PBS, stained with DAPI, and mounted with Antifade Mounting Media (Vector Labs, H-1700-10). Images were acquired with a Nikon T1-SM microscope.</p>
</sec>
<sec id="s4ac">
<title>Statistical analyses</title>
<p>Statistical analyses were performed with Microsoft Excel using Student’s t-test to create graphs displaying mean values with error bars corresponding to the standard error of the mean (SEM) for <italic>Klf16</italic> in vitro overexpression and animal experiments. p value &lt; 0.05 was considered significant. Sample sizes are indicated in figure legends. Image analyses were performed with ImageJ (National Institutes of Health). IHC data were quantified and visualized with GraphPad Prism 10 (GraphPad Software).</p>
</sec>
<sec id="s4ad" sec-type="data-availability">
<title>Data and code availability</title>
<p>The RNA-seq data supporting the findings of this study are deposited in Gene Expression Omnibus (GEO) with accession number GSE200492.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5" sec-type="additional-information">
<title>Additional information</title>
<sec id="s5a">
<title>Author contributions</title>
<list list-type="simple">
<list-item><p><bold>Ying Ru</bold>: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – original draft, Writing – review &amp; editing, Visualization, Supervision</p></list-item>
<list-item><p><bold>Meng Ma</bold>: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – original draft, Writing – review &amp; editing, Visualization</p></list-item>
<list-item><p><bold>Xianxiao Zhou</bold>: Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – original draft, Writing – review &amp; editing, Visualization</p></list-item>
<list-item><p><bold>Divya Kriti</bold>: Formal analysis, Investigation, Data curation, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Ninette Cohen</bold>: Investigation, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Sunita D’Souza</bold>: Methodology - iPSC derivation, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Christoph Schaniel</bold>: Methodology - iPSC derivation, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Susan M. Motch Perrine</bold>: Writing – review &amp; editing, Visualization</p></list-item>
<list-item><p><bold>Sharon Kuo</bold>: Writing – review &amp; editing, Visualization</p></list-item>
<list-item><p><bold>Oksana Pichurin</bold>: Investigation</p></list-item>
<list-item><p><bold>Dalila Pinto</bold>: Formal analysis, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Genevieve Housman</bold>: Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Greg Holmes</bold>: Conceptualization, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Eric Schadt</bold>: Conceptualization, Methodology, Writing – review &amp; editing</p></list-item>
<list-item><p><bold>Harm van Bakel</bold>: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – original draft, Writing – review &amp; editing, Visualization, Supervision</p></list-item>
<list-item><p><bold>Bin Zhang</bold>: Conceptualization, Methodology, Validation, Writing – review &amp; editing, Supervision</p></list-item>
<list-item><p><bold>Ethylin Wang Jabs</bold>: Conceptualization, Validation, Writing – review &amp; editing, Supervision, Project administration, Funding acquisition</p></list-item>
<list-item><p><bold>Meng Wu</bold>: Investigation, Writing – review &amp; editing, Supervision</p></list-item>
</list>
</sec>
</sec>
<sec id="s6">
<title>Supplementary Figures</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 1.</label>
<caption><title>Characterization of healthy human iPSCs and iPSC-derived MSCs.</title>
<p><bold>(A)</bold> Identification of stem cell markers: ALP staining, fluorescent immunocytochemistry (ICC) of pluripotency markers TRA-1-60, SOX2, OCT4, SSEA4, and NANOG. Scale bar: 100 μm. <bold>(B)</bold> Embryoid body (EB) formation in suspension from aggregates of iPSCs. ICC of three germ layer markers: AFP, endoderm; α-SMA, mesoderm; and TUBB3, ectoderm. Scale bar: 50 μm. <bold>(C)</bold> Fluorescence-activated cell sorting of CD105+/CD45- MSCs. FITC, fluorescein isothiocyanate; PE, phycoerythrin. <bold>(D)</bold> The percentage of mesenchymal surface marker CD105+/CD45- cells in total cells differentiated from iPSCs originated from PBMCs and fibroblasts. Data are shown as mean + SEM. <bold>(E)</bold> and <bold>(F)</bold> Analyses of MSCs after sorting and expansion with flow cytometry for MSC negative markers (CD31, CD34, and CD45) in <bold>(E)</bold> and MSC positive markers (CD29, CD73, CD90, and CD105) in <bold>(F)</bold> labeled with different fluorochromes (V450, APC, PE, and FITC). Marker expression is presented as histograms (green). Unstained cells were used as controls (gray). Data are shown as mean + SEM. <bold>(G)</bold> Gene expression of MSC markers in transcripts per kilobase million (TPM). <bold>(H)</bold> Spindle-like morphology of iPSC-derived MSCs. Scale bar: 50 μm.</p></caption>
<graphic xlink:href="579844v2_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 2.</label>
<caption><title>Gene Ontology (GO) enrichment of TF regulatory network modules.</title>
<p><bold>(A)</bold> Top enriched GO cellular component (CC) terms of each module. <bold>(B)</bold> Top enriched GO molecular function (MF) terms of each module.</p></caption>
<graphic xlink:href="579844v2_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 3.</label>
<caption><title>Gene expression pattern across osteogenic differentiation stages using pseudobulk single-cell RNA-seq data in <xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>.</title>
<p>KNR_TF_up: top five up-regulated KNR transcription factors; KNR_TF_down: top five down-regulated KNR transcription factors; TFs: top five transcription factors (TFs) based on TF regulatory network; osteogenic_markers: five known osteogenic markers.</p></caption>
<graphic xlink:href="579844v2_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Supplementary Figure 4.</label>
<caption><title>Expression of osteoclastogenesis markers in the femur bone of WT and <italic>Klf16<sup>+/-</sup></italic> mice.</title>
<p><bold>(A)</bold> IHC for CALCR in the distal femur bone. The CALCR-positive areas in epiphysis and metaphysis of two <italic>Klf16<sup>+/-</sup></italic> mice and two WT mice were quantified and shown as the percentage of CALCR-positive area (fluorescence-positive area/total bone area) in <bold>(B)</bold>. <bold>(C)</bold> IHC for RANKL in the distal femur bone. The percentage of RANKL-positive area were quantified and shown in <bold>(D)</bold>. For <bold>(B)</bold> and <bold>(D)</bold>, three replicate sections from each animal were analyzed. Data are presented as the mean ± SEM and visualized with GraphPad Prism 10. n.s: not significant. * p value &lt; 0.05 by unpaired t-test. Scale bar: 500 µm.</p></caption>
<graphic xlink:href="579844v2_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Paige Cundiff for support in iPSC derivation, Arvind Babu for chromosome analyses, Xuqiang Qiao for assistance in the Dean’s Flow Cytometry Core, and Jacqui White and Arie Mobley of The Jackson Laboratory Center for Biometric Analysis for the microCT imaging and DEXA scanning of the <italic>Klf16</italic> mouse line. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. The research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award numbers S10OD026880 and S10OD030463. This work was funded by NIH grants P01HD078233 (Ethylin Wang Jabs) and R01DE029832 (Ethylin Wang Jabs, Susan M. Motch Perrine) and F32AR075397 (Genevieve Housman). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
</ack>
<sec id="suppd1e2312" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="d1e2253">
<label>Supplementary Table 1</label>
<caption>
<title>related to <xref rid="fig1" ref-type="fig">Figure 1</xref>. Sample demographic metadata.</title>
</caption>
<media xlink:href="supplements/579844_file03.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2260">
<label>Supplementary Table 2</label>
<caption>
<title>related to <xref rid="fig2" ref-type="fig">Figure 2</xref>. Differential gene expression between stages.</title>
</caption>
<media xlink:href="supplements/579844_file04.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2267">
<label>Supplementary Table 3</label>
<caption>
<title>related to <xref rid="fig3" ref-type="fig">Figure 3</xref>. and Supplementary Figure 2. Transcription factor regulatory networks and gene ontology enrichments.</title>
</caption>
<media xlink:href="supplements/579844_file05.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2274">
<label>Supplementary Table 4</label>
<caption>
<title>related to <xref rid="fig4" ref-type="fig">Figure 4</xref>. Significant MEGENA modules.</title>
</caption>
<media xlink:href="supplements/579844_file06.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2282">
<label>Supplementary Table 5</label>
<caption>
<title>related to Supplementary Figure 3. Pseudobulk gene expression at osteogenic differentiation stages using single-cell RNA-seq data in <xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>.</title>
</caption>
<media xlink:href="supplements/579844_file07.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2289">
<label>Supplementary Table 6</label>
<caption>
<title>related to Supplementary Figure 3. Gene expression in five cell types at Day 21 of osteogenic differentiation using single-cell RNA-seq data in <xref ref-type="bibr" rid="c30">Housman et al., 2022</xref>.</title>
</caption>
<media xlink:href="supplements/579844_file08.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2296">
<label>Supplementary Table 7</label>
<caption>
<title>related to <xref rid="fig5" ref-type="fig">Figure 5</xref>. Primers used for <italic>Klf16</italic> in vitro overexpression study.</title>
</caption>
<media xlink:href="supplements/579844_file09.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2303">
<label>Source data</label>
<caption>
<title>Supplementary Source Data for <xref rid="fig5" ref-type="fig">Figure 5</xref>, Supplementary Figure 1, and Supplementary Figure 4.</title>
</caption>
<media xlink:href="supplements/579844_file10.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Al-Rekabi</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Wheeler</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Leonard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fura</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Juhlin</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Frazar</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>S. S.</given-names></string-name>, <string-name><surname>Gustafson</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Clarke</surname>, <given-names>C. M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Activation of the IGF1 pathway mediates changes in cellular contractility and motility in single-suture craniosynostosis</article-title>. <source>Journal of Cell Science</source> <volume>129</volume>, <fpage>483</fpage>–<lpage>491</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ardlie</surname>, <given-names>K. G.</given-names></string-name>, <string-name><surname>Deluca</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Segrè</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Sullivan</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Gelfand</surname>, <given-names>E. T.</given-names></string-name>, <string-name><surname>Trowbridge</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Maller</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Tukiainen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lek</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2015</year>). <article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</article-title>. <source>Science</source> <volume>348</volume>, <fpage>648</fpage>–<lpage>660</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aza-Carmona</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Barca-Tierno</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Hisado-Oliva</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Belinchón</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gorbenko-del Blanco</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rodriguez</surname>, <given-names>J. I.</given-names></string-name>, <string-name><surname>Benito-Sanz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Campos-Barros</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Heath</surname>, <given-names>K. E</given-names></string-name></person-group>. (<year>2014</year>). <article-title>NPPB and ACAN, two novel SHOX2 transcription targets implicated in skeletal development</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e83104</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barberi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Willis</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Socci</surname>, <given-names>N. D.</given-names></string-name> and <string-name><surname>Studer</surname>, <given-names>L</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Derivation of multipotent mesenchymal precursors from human embryonic stem cells</article-title>. <source>PLoS Medicine</source> <volume>2</volume>, <fpage>e161</fpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><string-name><surname>Bastian</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Heymann</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Jacomy</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Gephi: an open source software for exploring and manipulating networks</article-title>. <conf-name>Proceedings of the International AAAI Conference on Web and Social Media</conf-name> <volume>3</volume>, <fpage>361</fpage>–<lpage>362</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benisch</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Schilling</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Klein-Hitpass</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Frey</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Seefried</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Raaijmakers</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Krug</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Regensburger</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zeck</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schinke</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2012</year>). <article-title>The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors</article-title>. <source>PLoS One</source> <volume>7</volume>, <fpage>e45142</fpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benjamini</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Hochberg</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>1995</year>). <article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title>. <source>Journal of the Royal Statistical Society: Series B (Methodological)</source> <volume>57</volume>, <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boyce</surname>, <given-names>B. F</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Advances in the regulation of osteoclasts and osteoclast functions</article-title>. <source>Journal of Dental Research</source> <volume>92</volume>, <fpage>860</fpage>–<lpage>867</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boyle</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Simonet</surname>, <given-names>W. S.</given-names></string-name> and <string-name><surname>Lacey</surname>, <given-names>D. L</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Osteoclast differentiation and activation</article-title>. <source>Nature</source> <volume>423</volume>, <fpage>337</fpage>–<lpage>342</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bruder</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Fink</surname>, <given-names>D. J.</given-names></string-name> and <string-name><surname>Caplan</surname>, <given-names>A. I</given-names></string-name></person-group>. (<year>1994</year>). <article-title>Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy</article-title>. <source>Journal of Cellular Biochemistry</source> <volume>56</volume>, <fpage>283</fpage>–<lpage>294</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camacho</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>de la Fuente</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Mendes</surname>, <given-names>P.</given-names></string-name></person-group> (<year>2005</year>). <article-title>The origin of correlations in metabolomics data</article-title>. <source>Metabolomics</source> <volume>1</volume>, <fpage>53</fpage>–<lpage>63</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carcamo-Orive</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hoffman</surname>, <given-names>G. E.</given-names></string-name>, <string-name><surname>Cundiff</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Quertermous</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Carcamo-orive</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hoffman</surname>, <given-names>G. E.</given-names></string-name>, <string-name><surname>Cundiff</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Beckmann</surname>, <given-names>N. D.</given-names></string-name> and <string-name><surname>Souza</surname>, <given-names>S. L. D</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity resource analysis of tanscriptional variability in a large human iPSC library reveals genetic and non-genetic determinant</article-title>. <source>Stem Cell</source> <volume>20</volume>, <fpage>518</fpage>–<lpage>531</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Jiao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Jin</surname>, <given-names>T</given-names></string-name></person-group>. (<year>2017</year>). <article-title>CHI3L1 regulation of inflammation and the effects on osteogenesis in a Staphylococcus aureus-induced murine model of osteomyelitis</article-title>. <source>The FEBS Journal</source> <volume>284</volume>, <fpage>1738</fpage>–<lpage>1747</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chèneby</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ménétrier</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Mestdagh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rosnet</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Douida</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rhalloussi</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Bergon</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lopez</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Ballester</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2020</year>). <article-title>ReMap 2020: a database of regulatory regions from an integrative analysis of Human and Arabidopsis DNA-binding sequencing experiments</article-title>. <source>Nucleic Acids Research</source> <volume>48</volume>, <fpage>180</fpage>–<lpage>188</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Daftary</surname>, <given-names>G. S.</given-names></string-name>, <string-name><surname>Lomberk</surname>, <given-names>G. A.</given-names></string-name>, <string-name><surname>Buttar</surname>, <given-names>N. S.</given-names></string-name>, <string-name><surname>Allen</surname>, <given-names>T. W.</given-names></string-name>, <string-name><surname>Grzenda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Mathison</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Gada</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Calvo</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Detailed structural-functional analysis of the Krüppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology</article-title>. <source>Journal of Biological Chemistry</source> <volume>287</volume>, <fpage>7010</fpage>–<lpage>7025</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Daley</surname>, <given-names>G. Q.</given-names></string-name>, <string-name><surname>Lensch</surname>, <given-names>M. W.</given-names></string-name>, <string-name><surname>Jaenisch</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Meissner</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Plath</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Yamanaka</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Broader implications of defining standards for the pluripotency of iPSCs</article-title>. <source>Cell Stem Cell</source> <volume>4</volume>, <fpage>200</fpage>–<lpage>201</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>DeMars</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Stephens</surname>, <given-names>N. B.</given-names></string-name>, <string-name><surname>Saers</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Gordon</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Stock</surname>, <given-names>J. T.</given-names></string-name>, and <string-name><surname>Ryan</surname>, <given-names>T. M</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Using point clouds to investigate the relationship between trabecular bone phenotype and behavior: An example utilizing the human calcaneus</article-title>. <source>American Journal of Human Biology</source> <volume>33</volume>, <fpage>e23468</fpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dittrich</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Klau</surname>, <given-names>G. W.</given-names></string-name>, <string-name><surname>Rosenwald</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Dandekar</surname>, <given-names>T.</given-names></string-name> and <string-name><surname>Müller</surname>, <given-names>T</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Identifying functional modules in protein-protein interaction networks: an integrated exact approach</article-title>. <source>Bioinformatics</source> <volume>24</volume>, <fpage>i223</fpage>–<lpage>231</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Schlesinger</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Gingeras</surname>, <given-names>T. R</given-names></string-name></person-group>. (<year>2013</year>). <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source> <volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doube</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kłosowski</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Arganda-Carreras</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Cordeliéres</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Dougherty</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Jackson</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Schmid</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Hutchinson</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Shefelbine</surname>, <given-names>S. J</given-names></string-name></person-group>. (<year>2010</year>). <article-title>BoneJ: free and extensible bone image analysis in ImageJ</article-title>. <source>Bone</source> <volume>47</volume>, <fpage>1076</fpage>–<lpage>1079</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dubey</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Hoffman</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Schuebel</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Martinez</surname>, <given-names>P. E.</given-names></string-name>, <string-name><surname>Nieman</surname>, <given-names>L. K.</given-names></string-name>, <string-name><surname>Rubinow</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>Schmidt</surname>, <given-names>P. J.</given-names></string-name> and <string-name><surname>Goldman</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2017</year>). <article-title>The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder</article-title>. <source>Molecular Psychiatry</source> <volume>22</volume>, <fpage>1172</fpage>–<lpage>1184</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fu</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lv</surname>, <given-names>W. C.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Gong</surname>, <given-names>M. Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X. J.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yao</surname>, <given-names>Q. Q.</given-names></string-name>, <string-name><surname>Di</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis</article-title>. <source>Nature Communications</source> <volume>11</volume>, <fpage>460</fpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gerstein</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Kundaje</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hariharan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Landt</surname>, <given-names>S. G.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mu</surname>, <given-names>X. J.</given-names></string-name>, <string-name><surname>Khurana</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Rozowsky</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Alexander</surname>, <given-names>R.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Architecture of the human regulatory network derived from ENCODE data</article-title>. <source>Nature</source> <volume>489</volume>, <fpage>91</fpage>–<lpage>100</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giuliani</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Oudrhiri</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Noman</surname>, <given-names>Z. M.</given-names></string-name>, <string-name><surname>Vernochet</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Chouaib</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Azzarone</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Durrbach</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Bennaceur-Griscelli</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery</article-title>. <source>Blood</source> <volume>118</volume>, <fpage>3254</fpage>–<lpage>3262</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gross</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kivell</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Skinner</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Pahr</surname>, <given-names>D. H</given-names></string-name></person-group>. (<year>2014</year>). <article-title>A CT-image-based framework for the holistic analysis of cortical and trabecular bone morphology</article-title>. <source>Palaeontologia Electronica</source> <volume>17</volume>, <fpage>13</fpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Han</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Ding</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Mesenchymal stem cells for regenerative medicine</article-title>. <source>Cells</source> <volume>8</volume>, <fpage>886</fpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Dalmolin</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tian</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Cao</surname>, <given-names>W</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Prediction of long noncoding RNA functions with co-expression network in esophageal squamous cell carcinoma</article-title>. <source>BMC Cancer</source> <volume>15</volume>, <fpage>168</fpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernández-Vega</surname>, <given-names>A. M.</given-names></string-name> and <string-name><surname>Camacho-Arroyo</surname>, <given-names>I</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Crosstalk between 17β-estradiol and TGF-β signaling modulates glioblastoma progression</article-title>. <source>Brain Sciences</source> <volume>11</volume>, <fpage>564</fpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holmes</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Gonzalez-Reiche</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Rivera</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kriti</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sebra</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Donovan</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Potter</surname>, <given-names>S. S.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>Integrated transcriptome and network analysis reveals spatiotemporal dynamics of calvarial suturogenesis</article-title>. <source>Cell Reports</source> <volume>32</volume>, <fpage>107871</fpage>–<lpage>107871</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Housman</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Briscoe</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Gilad</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Evolutionary insights into primate skeletal gene regulation using a comparative cell culture model</article-title>. <source>PLOS Genetics</source> <volume>18</volume>, <fpage>e1010073</fpage>–<lpage>e1010073</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsu</surname>, <given-names>Y. H.</given-names></string-name>, <string-name><surname>Estrada</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Evangelou</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ackert-Bicknell</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Akesson</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Beck</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Capellini</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Carbone</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Cauley</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>Meta-analysis of genomewide association studies reveals genetic variants for hip bone geometry</article-title>. <source>Journal of Bone and Mineral Research</source> <volume>34</volume>, <fpage>1284</fpage>–<lpage>1296</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname>, <given-names>C. K.</given-names></string-name>, <string-name><surname>D’Souza</surname>, <given-names>U. M.</given-names></string-name>, <string-name><surname>Eisch</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Yajima</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lammers</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>Y. M.</given-names></string-name>, <string-name><surname>Nestler</surname>, <given-names>E. J.</given-names></string-name> and <string-name><surname>Mouradian</surname>, <given-names>M. M</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>98</volume>, <fpage>7558</fpage>–<lpage>7563</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Z.</given-names></string-name> and <string-name><surname>Shen</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Key regulators in prostate cancer identified by co-expression module analysis</article-title>. <source>BMC Genomics</source> <volume>15</volume>, <fpage>1015</fpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Julien</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kanagalingam</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Martínez-Sarrà</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Megret</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Luka</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ménager</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Relaix</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Colnot</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Direct contribution of skeletal muscle mesenchymal progenitors to bone repair</article-title>. <source>Nature Communications</source> <volume>12</volume>, <fpage>2860</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaczynski</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>T.</given-names></string-name> and <string-name><surname>Urrutia</surname>, <given-names>R</given-names></string-name></person-group>. (<year>2003</year>). <article-title>Sp1- and Krüppel-like transcription factors</article-title>. <source>Genome Biol</source> <volume>4</volume>, <fpage>206</fpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Aagaard</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bünger</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bolund</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Luo</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity</article-title>. <source>Stem Cell Research &amp; Therapy</source> <volume>6</volume>, <fpage>144</fpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khosla</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2001</year>). <article-title>Minireview: The OPG/RANKL/RANK System</article-title>. <source>Endocrinology</source> <volume>142</volume>, <fpage>5050</fpage>–<lpage>5055</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Komori</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yagi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Nomura</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Yamaguchi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sasaki</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Deguchi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Shimizu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Bronson</surname>, <given-names>R. T.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>Y. H.</given-names></string-name>, <string-name><surname>Inada</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>1997</year>). <article-title>Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts</article-title>. <source>Cell</source> <volume>89</volume>, <fpage>755</fpage>–<lpage>764</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krum</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Miranda-Carboni</surname>, <given-names>G.</given-names></string-name> and <string-name><surname>Wang</surname>, <given-names>C. Y</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Novel functions for NFκB: inhibition of bone formation</article-title>. <source>Nature Reviews Rheumatology</source> <volume>6</volume>, <fpage>607</fpage>–<lpage>611</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kukita</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bonewald</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rosen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Seyedin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mundy</surname>, <given-names>G. R.</given-names></string-name> and <string-name><surname>Roodman</surname>, <given-names>G. D</given-names></string-name></person-group>. (<year>1990</year>). <article-title>Osteoinductive factor inhibits formation of human osteoclast-like cells</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>87</volume>, <fpage>3023</fpage>–<lpage>3026</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kushioka</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kaito</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Okada</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ishiguro</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Bal</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Kodama</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chijimatsu</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Pye</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Narimatsu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wrana</surname>, <given-names>J. L.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>A novel negative regulatory mechanism of Smurf2 in BMP/Smad signaling in bone</article-title>. <source>Bone Research</source> <volume>8</volume>, <fpage>41</fpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lamande</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Ng</surname>, <given-names>E. S.</given-names></string-name>, <string-name><surname>Cameron</surname>, <given-names>T. L.</given-names></string-name>, <string-name><surname>Kung</surname>, <given-names>L. H. W.</given-names></string-name>, <string-name><surname>Sampurno</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rowley</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lilianty</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Patria</surname>, <given-names>Y. N.</given-names></string-name>, <string-name><surname>Stenta</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hanssen</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2023</year>). <article-title>Modeling human skeletal development using human pluripotent stem cells</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>120</volume>, <fpage>e2211510120</fpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Jolma</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Campitelli</surname>, <given-names>L. F.</given-names></string-name>, <string-name><surname>Das</surname>, <given-names>P. K.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Albu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Taipale</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hughes</surname>, <given-names>T. R.</given-names></string-name> and <string-name><surname>Weirauch</surname>, <given-names>M. T</given-names></string-name></person-group>. (<year>2018</year>). <article-title>The human transcription factors</article-title>. <source>Cell</source> <volume>175</volume>, <fpage>598</fpage>–<lpage>599</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Law</surname>, <given-names>C. W.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>W.</given-names></string-name> and <string-name><surname>Smyth</surname>, <given-names>G. K</given-names></string-name></person-group>. (<year>2014</year>). <article-title>voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title>. <source>Genome Biology</source> <volume>15</volume>, <fpage>R29</fpage>–<lpage>R29</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Mée</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fromigué</surname>, <given-names>O.</given-names></string-name> and <string-name><surname>Marie</surname>, <given-names>P. J.</given-names></string-name></person-group> (<year>2005</year>). <article-title>Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts</article-title>. <source>Experimental Cell Research</source> <volume>302</volume>, <fpage>129</fpage>–<lpage>142</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>D.-F.</given-names></string-name>, <string-name><surname>Su</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Papatsenko</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Gingold</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xia</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Darr</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Modeling familial cancer with induced pluripotent stem cells</article-title>. <source>Cell</source> <volume>161</volume>, <fpage>240</fpage>–<lpage>254</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lewis</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Cleal</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Ntani</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Crozier</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Mahon</surname>, <given-names>P. A.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Harvey</surname>, <given-names>N. C.</given-names></string-name>, <string-name><surname>Cooper</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Inskip</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Godfrey</surname>, <given-names>K. M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Relationship between placental expression of the imprinted PHLDA2 gene, intrauterine skeletal growth and childhood bone mass</article-title>. <source>Bone</source> <volume>50</volume>, <fpage>337</fpage>–<lpage>342</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>B.</given-names></string-name> and <string-name><surname>Dewey</surname>, <given-names>C. N</given-names></string-name></person-group>. (<year>2011</year>). <article-title>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</article-title>. <source>BMC bioinformatics</source> <volume>12</volume>, <fpage>323</fpage>–<lpage>323</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Jie</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Oxidative stress-induced hypermethylation of KLF5 promoter mediated by DNMT3B impairs osteogenesis by diminishing the interaction with β-Catenin</article-title>. <source>Antioxid Redox Signal</source> <volume>35</volume>, <fpage>1</fpage>–<lpage>20</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>X.</given-names></string-name> and <string-name><surname>Wang</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2021</year>). <article-title>From bulk, single-cell to spatial RNA sequencing</article-title>. <source>International Journal of Oral Science</source> <volume>13</volume>, <fpage>36</fpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Smyth</surname>, <given-names>G. K.</given-names></string-name> and <string-name><surname>Shi</surname>, <given-names>W</given-names></string-name></person-group>. (<year>2014</year>). <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source>Bioinformatics</source> <volume>30</volume>, <fpage>923</fpage>–<lpage>930</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Chen</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2008</year>). <chapter-title>Embryoid body formation from human pluripotent stem cells in chemically defined E8 media</chapter-title>. In <source>StemBook</source>. <publisher-loc>Cambridge (MA)</publisher-loc>: <publisher-name>Harvard Stem Cell Institute</publisher-name>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ping</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zaidi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ji</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lou</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Anabolic actions of Notch on mature bone</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>113</volume>, <fpage>E2152</fpage>–<lpage>2161</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name> and <string-name><surname>Wang</surname>, <given-names>C. S</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Investigation of transcriptome mechanism associated with osteoporosis explored by microarray analysis</article-title>. <source>Experimental and Therapeutic Medicine</source> <volume>17</volume>, <fpage>3459</fpage>–<lpage>3464</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hao</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Wang</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition</article-title>. <source>Stem Cell Research &amp; Therapy</source> <volume>10</volume>, <fpage>19</fpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Manikandan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Abuelreich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Elsafadi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Alsalman</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Almalak</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Siyal</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hashmi</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Aldahmash</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kassem</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Alfayez</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2018</year>). <article-title>NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC</article-title>. <source>Differentiation</source> <volume>104</volume>, <fpage>36</fpage>–<lpage>41</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>. <source>EMBnet.journal</source> <volume>17</volume>, <fpage>10</fpage>–<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsuda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yamanaka</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Uemura</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Osawa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Saito</surname>, <given-names>M. K.</given-names></string-name>, <string-name><surname>Nagahashi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nishio</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ikegawa</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sakurai</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>Recapitulating the human segmentation clock with pluripotent stem cells</article-title>. <source>Nature</source> <volume>580</volume>, <fpage>124</fpage>–<lpage>129</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Muruganujan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ebert</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name> and <string-name><surname>Thomas</surname>, <given-names>P. D</given-names></string-name></person-group>. (<year>2019a</year>). <article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title>. <source>Nucleic Acids Res</source> <volume>47</volume>, <fpage>D419</fpage>–<lpage>D426</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Muruganujan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ebert</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Mills</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>X.</given-names></string-name> and <string-name><surname>Thomas</surname>, <given-names>P. D</given-names></string-name></person-group>. (<year>2019b</year>). <article-title>Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)</article-title>. <source>Nature Protocols</source> <volume>14</volume>, <fpage>703</fpage>–<lpage>721</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morris</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Kemp</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Youlten</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Laurent</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Logan</surname>, <given-names>J. G.</given-names></string-name>, <string-name><surname>Chai</surname>, <given-names>R. C.</given-names></string-name>, <string-name><surname>Vulpescu</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Forgetta</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Kleinman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mohanty</surname>, <given-names>S. T.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>An atlas of genetic influences on osteoporosis in humans and mice</article-title>. <source>Nature Genetics</source> <volume>51</volume>, <fpage>258</fpage>–<lpage>266</lpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakajima</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Shibata</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nishio</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nagata</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Alev</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Sakurai</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Toguchida</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Ikeya</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells</article-title>. <source>Development</source> <volume>145</volume>(<issue>16</issue>), <fpage>dev165431</fpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakashima</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Kunkel</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Behringer</surname>, <given-names>R. R.</given-names></string-name> and <string-name><surname>de Crombrugghe</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2002</year>). <article-title>The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation</article-title>. <source>Cell</source> <volume>108</volume>, <fpage>17</fpage>–<lpage>29</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicholson</surname>, <given-names>G. C.</given-names></string-name>, <string-name><surname>Moseley</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Sexton</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Mendelsohn</surname>, <given-names>F. A.</given-names></string-name> and <string-name><surname>Martin</surname>, <given-names>T. J</given-names></string-name></person-group>. (<year>1986</year>). <article-title>Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization</article-title>. <source>Journal of Clinical Investigation</source> <volume>78</volume>, <fpage>355</fpage>–<lpage>360</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Onizuka</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Iwata</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Nakai</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Yamato</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Okano</surname>, <given-names>T.</given-names></string-name> and <string-name><surname>Izumi</surname>, <given-names>Y</given-names></string-name></person-group>. (<year>2016</year>). <article-title>ZBTB16 as a downstream target gene of osterix regulates osteoblastogenesis of human multipotent mesenchymal stromal cells</article-title>. <source>Journal of Cellular Biochemistry</source> <volume>117</volume>, <fpage>2423</fpage>–<lpage>2434</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Otasek</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Bouças</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pico</surname>, <given-names>A. R.</given-names></string-name> and <string-name><surname>Demchak</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2019</year>). <article-title>Cytoscape Automation: empowering workflow-based network analysis</article-title>. <source>Genome Biology</source> <volume>20</volume>, <fpage>185</fpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oury</surname>, <given-names>F</given-names></string-name></person-group>. (<year>2012</year>). <article-title>A crosstalk between bone and gonads</article-title>. <source>Annals of the New York Academy of Sciences</source> <volume>1260</volume>, <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parfitt</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Drezner</surname>, <given-names>M. K.</given-names></string-name>, <string-name><surname>Glorieux</surname>, <given-names>F. H.</given-names></string-name>, <string-name><surname>Kanis</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Malluche</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Meunier</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Ott</surname>, <given-names>S. M.</given-names></string-name> and <string-name><surname>Recker</surname>, <given-names>R. R</given-names></string-name></person-group>. (<year>1987</year>). <article-title>Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee</article-title>. <source>Journal of Bone and Mineral Research</source> <volume>2</volume>, <fpage>595</fpage>–<lpage>610</lpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pittenger</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Mackay</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Beck</surname>, <given-names>S. C.</given-names></string-name>, <string-name><surname>Jaiswal</surname>, <given-names>R. K.</given-names></string-name>, <string-name><surname>Douglas</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mosca</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Moorman</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Simonetti</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Craig</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Marshak</surname>, <given-names>D. R</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Multilineage potential of adult human mesenchymal stem cells</article-title>. <source>Science</source> <volume>284</volume>, <fpage>143</fpage>–<lpage>147</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Polo</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Figueroa</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Kulalert</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Eminli</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>K. Y.</given-names></string-name>, <string-name><surname>Apostolou</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Stadtfeld</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shioda</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells</article-title>. <source>Nature Biotechnology</source> <volume>28</volume>, <fpage>848</fpage>–<lpage>855</lpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quinlan</surname>, <given-names>A. R.</given-names></string-name> and <string-name><surname>Hall</surname>, <given-names>I. M</given-names></string-name></person-group>. (<year>2010</year>). <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source> <volume>26</volume>, <fpage>841</fpage>–<lpage>842</lpage>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rauch</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Haakonsson</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Madsen</surname>, <given-names>J. G. S.</given-names></string-name>, <string-name><surname>Larsen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Forss</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Madsen</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Van Hauwaert</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Wiwie</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Jespersen</surname>, <given-names>N. Z.</given-names></string-name>, <string-name><surname>Tencerova</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis</article-title>. <source>Nature Genetics</source> <volume>51</volume>, <fpage>716</fpage>–<lpage>727</lpage>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname>, <given-names>M. E.</given-names></string-name>, <string-name><surname>Phipson</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Law</surname>, <given-names>C. W.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>W.</given-names></string-name> and <string-name><surname>Smyth</surname>, <given-names>G. K</given-names></string-name></person-group>. (<year>2015</year>). <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Research</source> <volume>43</volume>, <fpage>e47</fpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roforth</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Farr</surname>, <given-names>J. N.</given-names></string-name>, <string-name><surname>Fujita</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>McCready</surname>, <given-names>L. K.</given-names></string-name>, <string-name><surname>Atkinson</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Therneau</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Cunningham</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Drake</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Monroe</surname>, <given-names>D. G.</given-names></string-name> and <string-name><surname>Khosla</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Global transcriptional profiling using RNA sequencing and DNA methylation patterns in highly enriched mesenchymal cells from young versus elderly women</article-title>. <source>Bone</source> <volume>76</volume>, <fpage>49</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rojas-Peña</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Olivares-Navarrete</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hyzy</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Arafat</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Boyan</surname>, <given-names>B. D.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Gibson</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2014</year>). <article-title>Characterization of distinct classes of differential gene expression in osteoblast cultures from non-syndromic craniosynostosis bone</article-title>. <source>Journal of Genomics</source> <volume>2</volume>, <fpage>121</fpage>–<lpage>130</lpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaniel</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Dhanan</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Xiong</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Raghunandan</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gonzalez</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Dariolli</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>D’Souza</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Yadaw</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Hansen</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals</article-title>. <source>Stem Cell Reports</source> <volume>16</volume>, <fpage>3036</fpage>–<lpage>3049</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schroeder</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Jensen</surname>, <given-names>E. D.</given-names></string-name> and <string-name><surname>Westendorf</surname>, <given-names>J. J</given-names></string-name></person-group>. (<year>2005</year>). <article-title>Runx2: A master organizer of gene transcription in developing and maturing osteoblasts</article-title>. <source>Birth Defects Research Part C: Embryo Today: Reviews</source> <volume>75</volume>, <fpage>213</fpage>–<lpage>225</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scotto di Carlo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Pazzaglia</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Esposito</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Gianfrancesco</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2020</year>). <article-title>The loss of profilin 1 causes early onset paget’s disease of bone</article-title>. <source>Journal of Bone and Mineral Research</source> <volume>35</volume>, <fpage>1387</fpage>–<lpage>1398</lpage>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seifert</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Werheid</surname>, <given-names>D. F.</given-names></string-name>, <string-name><surname>Knapp</surname>, <given-names>S. M.</given-names></string-name> and <string-name><surname>Tobiasch</surname>, <given-names>E</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Role of Hox genes in stem cell differentiation</article-title>. <source>World J Stem Cells</source> <volume>7</volume>, <fpage>583</fpage>–<lpage>595</lpage>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shinoda</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ogata</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Higashikawa</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Manabe</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Shindo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yamada</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kugimiya</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Ikeda</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kawamura</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kawasaki</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9</article-title>. <source>Journal of Biological Chemistry</source> <volume>283</volume>, <fpage>24682</fpage>–<lpage>24689</lpage>.</mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname>, <given-names>W. M.</given-names></string-name> and <string-name><surname>Zhang</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Multiscale embedded gene co-expression network analysis</article-title>. <source>PLOS Computational Biology</source> <volume>11</volume>, <fpage>e1004574</fpage>–<lpage>e1004574</lpage>.</mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Lian</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xiang</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Li</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2017</year>). <article-title>KLF15 regulates in vitro chondrogenic differentiation of human mesenchymal stem cells by targeting SOX9</article-title>. <source>Biochemical and Biophysical Research Communications</source> <volume>493</volume>, <fpage>1082</fpage>–<lpage>1088</lpage>.</mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sotiropoulou</surname>, <given-names>P. A.</given-names></string-name>, <string-name><surname>Perez</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Salagianni</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baxevanis</surname>, <given-names>C. N.</given-names></string-name> and <string-name><surname>Papamichail</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells</article-title>. <source>Stem Cells</source> <volume>24</volume>, <fpage>462</fpage>–<lpage>471</lpage>.</mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spitzer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wildenhain</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rappsilber</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Tyers</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2014</year>). <article-title>BoxPlotR: a web tool for generation of box plots</article-title>. <source>Nature Methods</source> <volume>11</volume>, <fpage>121</fpage>–<lpage>122</lpage>.</mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Styrkarsdottir</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Stefansson</surname>, <given-names>O. A.</given-names></string-name>, <string-name><surname>Gunnarsdottir</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Thorleifsson</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lund</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Stefansdottir</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Juliusson</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Agustsdottir</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Zink</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Halldorsson</surname>, <given-names>G. H.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures</article-title>. <source>Nature Communications</source> <volume>10</volume>, <fpage>2054</fpage>.</mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zhong</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Miao</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance</article-title>. <source>Gut</source> <volume>70</volume>, <fpage>2183</fpage>–<lpage>2195</lpage>.</mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Zou</surname>, <given-names>W</given-names></string-name></person-group>. (<year>2020</year>). <article-title>VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription</article-title>. <source>Science Advances</source> <volume>6</volume>(<issue>43</issue>), <fpage>eaba4147</fpage>.</mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tani</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Okada</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Onodera</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Chijimatsu</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Seki</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Suzuki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Rowe</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Saito</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tanaka</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2023</year>). <article-title>Stem cell-based modeling and single-cell multiomics reveal gene-regulatory mechanisms underlying human skeletal development</article-title>. <source>Cell Reports</source> <volume>42</volume>, <fpage>112276</fpage>.</mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The Gene Ontology Consortium</collab></person-group> (<year>2019</year>). <article-title>The Gene Ontology Resource: 20 years and still GOing strong</article-title>. <source>Nucleic Acids Research</source> <volume>47</volume>, <fpage>D330</fpage>–<lpage>D338</lpage>.</mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thomas</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Jaganathan</surname>, <given-names>B. G</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Signaling network regulating osteogenesis in mesenchymal stem cells</article-title>. <source>J Cell Commun Signal</source> <volume>16</volume>, <fpage>47</fpage>–<lpage>61</lpage>.</mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Virtanen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gommers</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Oliphant</surname>, <given-names>T. E.</given-names></string-name>, <string-name><surname>Haberland</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Reddy</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Cournapeau</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Burovski</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Peterson</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Weckesser</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Bright</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2020</year>). <article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title>. <source>Nature Methods</source> <volume>17</volume>, <fpage>261</fpage>–<lpage>272</lpage>.</mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Galvao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Beach</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Urrutia</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Goldberg</surname>, <given-names>J. L.</given-names></string-name> and <string-name><surname>Otteson</surname>, <given-names>D. C</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Novel roles and mechanism for Krüppel-like factor 16 (KLF16) regulation of neurite outgrowth and ephrin receptor A5 (EphA5) expression in retinal ganglion cells</article-title>. <source>Journal of Biological Chemistry</source> <volume>291</volume>, <fpage>18084</fpage>–<lpage>18095</lpage>.</mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilkinson</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Nakauchi</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Göttgens</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Mammalian transcription factor networks: recent advances in interrogating biological complexity</article-title>. <source>Cell Systems</source> <volume>5</volume>, <fpage>319</fpage>–<lpage>331</lpage>.</mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Shan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Wang</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2021</year>). <article-title>High-mobility group AT-Hook 1 mediates the role of nuclear factor I/X in osteogenic differentiation through activating canonical Wnt signaling</article-title>. <source>Stem Cells</source> <volume>39</volume>, <fpage>1349</fpage>–<lpage>1361</lpage>.</mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yaffe</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>Noggle</surname>, <given-names>S. A.</given-names></string-name> and <string-name><surname>Solomon</surname>, <given-names>S. L</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Raising the standards of stem cell line quality</article-title>. <source>Nature Cell Biology</source> <volume>18</volume>, <fpage>236</fpage>–<lpage>237</lpage>.</mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Han</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Fan</surname>, <given-names>Z</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Secreted frizzled-related protein 2 promotes the osteo/odontogenic differentiation and paracrine potentials of stem cells from apical papilla under inflammation and hypoxia conditions</article-title>. <source>Cell Proliferation</source> <volume>53</volume>, <fpage>e12694</fpage>.</mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Matsuda</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bialek</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Jacquot</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Masuoka</surname>, <given-names>H. C.</given-names></string-name>, <string-name><surname>Schinke</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Brancorsini</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sassone-Corsi</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Townes</surname>, <given-names>T. M.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2004</year>). <article-title>ATF4 Is a substrate of RSK2 and an essential regulator of osteoblast biology: implication for Coffin-Lowry syndrome</article-title>. <source>Cell</source> <volume>117</volume>, <fpage>387</fpage>–<lpage>398</lpage>.</mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><string-name><surname>Yazdani</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Y. C.</given-names></string-name>, <string-name><surname>Stephens</surname>, <given-names>N. B.</given-names></string-name>, <string-name><surname>Ryan</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Monga</surname>, <given-names>V.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Multi-class micro-CT image segmentation using sparse regularized deep networks</article-title>. <conf-name>Conference Record of the 54th Asilomar Conference on Signals, Systems and Computers, ACSSC 2020 (IEEE Computer Society)</conf-name>, <fpage>1553</fpage>–<lpage>1557</lpage>.</mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Liao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>Y.</given-names></string-name> and <string-name><surname>Ye</surname>, <given-names>L</given-names></string-name></person-group>. (<year>2020</year>). <article-title>Wnt7b-induced Sox11 functions enhance self-renewal and osteogenic commitment of bone marrow mesenchymal stem cells</article-title>. <source>Stem Cells</source> <volume>38</volume>, <fpage>1020</fpage>–<lpage>1033</lpage>.</mixed-citation></ref>
<ref id="c100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zuo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>BMP2-dependent gene regulatory network analysis reveals Klf4 as a novel transcription factor of osteoblast differentiation</article-title>. <source>Cell Death &amp; Disease</source> <volume>12</volume>, <fpage>197</fpage>.</mixed-citation></ref>
<ref id="c101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zakeri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Aminian</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sadeghi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Esmaeilzadeh-Gharehdaghi</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Razmara</surname>, <given-names>E</given-names></string-name></person-group>. (<year>2022</year>). <article-title>Krüppel-like factors in bone biology</article-title>. <source>Cell Signal</source> <volume>93</volume>, <fpage>110308</fpage>.</mixed-citation></ref>
<ref id="c102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Gaiteri</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bodea</surname>, <given-names>L. G.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>McElwee</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Podtelezhnikov</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tran</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Dobrin</surname>, <given-names>R.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease</article-title>. <source>Cell</source> <volume>153</volume>, <fpage>707</fpage>–<lpage>720</lpage>.</mixed-citation></ref>
<ref id="c103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>B.</given-names></string-name> and <string-name><surname>Zhu</surname>, <given-names>J</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Identification of key causal regulators in gene networks</article-title>. In <source>Proceedings of the World Congress on Engineering</source>, <fpage>5</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>, <given-names>G. X.</given-names></string-name>, <string-name><surname>Terry</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Belgrader</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ryvkin</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Bent</surname>, <given-names>Z. W.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ziraldo</surname>, <given-names>S. B.</given-names></string-name>, <string-name><surname>Wheeler</surname>, <given-names>T. D.</given-names></string-name>, <string-name><surname>McDermott</surname>, <given-names>G. P.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2017</year>). <article-title>Massively parallel digital transcriptional profiling of single cells</article-title>. <source>Nature Communications</source> <volume>8</volume>, <fpage>14049</fpage>.</mixed-citation></ref>
<ref id="c105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ramnaraign</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>B. A.</given-names></string-name>, <string-name><surname>Tycksen</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Nunley</surname>, <given-names>R.</given-names></string-name> and <string-name><surname>McAlinden</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2019</year>). <article-title>MicroRNA-138 inhibits osteogenic differentiation and mineralization of human dedifferentiated chondrocytes by regulating RhoC and the actin cytoskeleton</article-title>. <source>JBMR Plus</source> <volume>3</volume>, <fpage>e10071</fpage>.</mixed-citation></ref>
<ref id="c106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Yao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Fang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Ni</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Shao</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Microarray analysis of Long non-coding RNA expression profiles in human gastric cells and tissues with Helicobacter pylori Infection</article-title>. <source>BMC Medical Genomics</source> <volume>8</volume>, <fpage>84</fpage>.</mixed-citation></ref>
<ref id="c107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2014</year>). <article-title>A gain-of-function mutation in Tnni2 impeded bone development through increasing Hif3a expression in DA2B mice</article-title>. <source>PLoS Genetics</source> <volume>10</volume>, <fpage>e1004589</fpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106265.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sugimura</surname>
<given-names>Rio</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>The University of Hong Kong</institution>
</institution-wrap>
<city>Pok Fu Lam</city>
<country>Hong Kong</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>The authors investigated KLF Transcription Factor 16 (KLF16) as an inhibitor of osteogenic differentiation, which plays a critical role in bone development, metabolism and repair. The results of the study are <bold>valuable</bold> as they could help to facilitate future research on the regulation of osteogenesis in vitro and in vivo. However, the evidence overall is <bold>incomplete</bold>, as validation by knockout mouse models would help to strengthen the conclusions.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106265.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this manuscript, Ru and colleagues investigated regulatory gene interactions during osteogenic differentiation. By profiling transcriptomic changes during mesenchymal stem cell differentiation, they identified KLF16 as a key transcription factor that inhibits osteogenic differentiation and mineralization. It was found that overexpression of KLF16 suppressed osteogenesis in vitro, while KLF16⁺/⁻ mice exhibited enhanced bone density, underscoring its regulatory role in bone formation.</p>
<p>Strengths:</p>
<p>(1) Bioinformatics is strong and comprehensive.</p>
<p>(2) Identification of KLF16 in osteoblast differentiation is exciting and innovative.</p>
<p>Weaknesses:</p>
<p>(1) The mechanism of KLF16 function is not studied.</p>
<p>(2) Studies of KLF16 in bone development, from both in vitro and in vivo perspectives, are descriptive.</p>
<p>(3) Findings in bioinformatics analysis are mostly redundant with previous studies in the field, and can be simplified.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106265.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In their manuscript with the title &quot;Integrated transcriptomic analysis of human induced pluripotent stem cell (iPSC)-derived osteogenic differentiation reveals a regulatory role of KLF16&quot;, Ru et al. have analyzed the gene expression changes during the osteogenic differentiation of iPSC-derived mesenchymal stem/stromal cells into preosteoblasts and osteoblasts. As part of the computational analyses, they have investigated the transcription factor regulatory network mediating this differentiation process, which has also led to the identification of the transcription factor KLF16. Overexpression experiments in vitro and the analysis of heterozygous KLF16 knockout mice in vivo indicate that KLF16 is an inhibitor of osteogenic differentiation.</p>
<p>The integrated analysis of iPSC bulk transcriptomic data is a major strength of the study, and it is also great that the authors provide deeper functional characterization of the transcription factor KLF16, one of the newly identified candidate regulators of osteogenic differentiation.</p>
<p>However, characterization of KLF16 expression in the mouse and validation of the knockout model are currently lacking. Alternative explanations for the mutant phenotype should be considered to improve the strength of the conclusions.</p>
<p>If all issues can be addressed, the study would provide an important resource for the field that would facilitate future research on the regulation of osteogenesis in vitro and in vivo, with potential implications for preclinical and clinical research as well as bioengineering.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106265.1.sa3</article-id>
<title-group>
<article-title>Author response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ru</surname>
<given-names>Ying</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Meng</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Xianxiao</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kriti</surname>
<given-names>Divya</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cohen</surname>
<given-names>Ninette</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Souza</surname>
<given-names>Sunita</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaniel</surname>
<given-names>Christoph</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Motch Perrine</surname>
<given-names>Susan M</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3412-221X</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Kuo</surname>
<given-names>Sharon</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pichurin</surname>
<given-names>Oksana</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinto</surname>
<given-names>Dalila</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Housman</surname>
<given-names>Genevieve</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holmes</surname>
<given-names>Greg</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0717-6722</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Schadt</surname>
<given-names>Eric</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Bakel</surname>
<given-names>Harm</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1376-6916</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Bin</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jabs</surname>
<given-names>Ethylin Wang</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Meng</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5512-9651</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>eLife Assessment</bold></p>
<p>The authors investigated KLF Transcription Factor 16 (KLF16) as an inhibitor of osteogenic differentiation, which plays a critical role in bone development, metabolism and repair. The results of the study are valuable as they could help to facilitate future research on the regulation of osteogenesis in vitro and in vivo. However, the evidence overall is incomplete, as validation by knockout mouse models would help to strengthen the conclusions.</p>
</disp-quote>
<p>We appreciate the editors’ evaluation and recognition of the importance of our research. The primary goal and value of our study is to provide robust bioinformatics analyses of 20 independent iPSC lines, which can lead to the identification of novel genes involved in osteogenic differentiation. The identification of <italic>KLF16</italic> serves to illustrate this goal. A thorough analysis of the function of any single gene both in vitro and in vivo is beyond the initial scope of this study. To validate KLF16’s inhibitory role in osteogenic differentiation, we provided evidence showing overexpression of <italic>Klf16</italic> suppressed osteogenic differentiation in vitro, and <italic>Klf16</italic><sup>+/-</sup> mice exhibited enhanced bone mineral content and density in vivo.</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Summary:</p>
<p>In this manuscript, Ru and colleagues investigated regulatory gene interactions during osteogenic differentiation. By profiling transcriptomic changes during mesenchymal stem cell differentiation, they identified KLF16 as a key transcription factor that inhibits osteogenic differentiation and mineralization. It was found that overexpression of KLF16 suppressed osteogenesis in vitro, while <italic>Klf16</italic><sup>+/-</sup> mice exhibited enhanced bone density, underscoring its regulatory role in bone formation.</p>
<p>Strengths:</p>
<p>(1) Bioinformatics is strong and comprehensive.</p>
<p>(2) Identification of KLF16 in osteoblast differentiation is exciting and innovative.</p>
</disp-quote>
<p>We appreciate the reviewer’s comments on our bioinformatic analyses of MSC osteogenic differentiation and the identification of KLF16 as a new osteogenesis regulator. The differentiation of iPSC-derived MSCs to OBs serves as a valuable model for investigating gene expression and regulatory networks in osteogenic differentiation. This study provides insights into the complex and dynamic regulation of the transcriptomic landscape in osteogenic differentiation and supplies a foundational resource for additional investigation into normal bone formation and the mechanisms underlying pathological conditions.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>(1) The mechanism of KLF16 function is not studied.</p>
<p>(2) Studies of KLF16 in bone development, from both in vitro and in vivo perspectives, are descriptive.</p>
</disp-quote>
<p>Our study aims to apply rigorous bioinformatic analyses of 20 iPSC lines to identify novel genes involved in osteogenic differentiation. With this strategy, we successfully identified KLF16 as a regulator of osteogenic differentiation. We validated this with both in vitro and in vivo models even though we had limited availability of <italic>Klf16</italic> knockout mice when the study was conducted. We demonstrated that overexpression of <italic>Klf16</italic> suppressed osteogenesis in vitro, while <italic>Klf16</italic><sup>+/-</sup> mice exhibited increased bone mineral density, trabecular number, and cortical bone area, highlighting its role in bone formation. With these mice now available, further investigation into the mechanism of KLF16's function is possible.</p>
<disp-quote content-type="editor-comment">
<p>(3) Findings in bioinformatics analysis are mostly redundant with previous studies in the field, and can be simplified.</p>
</disp-quote>
<p>We compared our bulk RNA-seq data with our previously published single-cell RNA-seq (scRNA-seq) data generated from iPSC-induced cells during osteogenic differentiation (Housman et al., 2022). The purpose is to corroborate the expression patterns of the genes we focused on during osteogenic differentiation. We found similar differential expression patterns in a pseudobulk analysis of the scRNA-seq data, even though there are significant differences between these two studies, including: cell culture conditions, sequencing approaches (bulk vs. single cell), goals of the studies (key TF drivers of osteoblast differentiation vs. mapping differentiation stages and inter-species gene programs in human and chimp), and findings (identification of TFs vs. identification of interspecific regulatory differences) .</p>
<p>Importantly, we performed network analyses to identify key transcription factors, which were not redundant with previous studies. We constructed a transcription factor regulatory network analysis during human osteogenic differentiation, and identified a network organized into five interactive modules. The most exciting finding was the identification of KLF16 as one of the strongest regulators in Module 5 (Figure 3), which previously was not demonstrated to be involved in bone formation. We also demonstrated known TF genes regulating osteogenic differentiation in these modules, and performed gene ontology (GO) and reactome pathway (RP) analyses for regulatory functions and pathways specific to each module. To clarify that our findings do not overlap with previous studies, we will revise the manuscript focusing on Module 5 and simplify the description of the bioinformatics analysis as the reviewer suggested.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>In their manuscript with the title &quot;Integrated transcriptomic analysis of human induced pluripotent stem cell (iPSC)-derived osteogenic differentiation reveals a regulatory role of KLF16&quot;, Ru et al. have analyzed the gene expression changes during the osteogenic differentiation of iPSC-derived mesenchymal stem/stromal cells into preosteoblasts and osteoblasts. As part of the computational analyses, they have investigated the transcription factor regulatory network mediating this differentiation process, which has also led to the identification of the transcription factor KLF16. Overexpression experiments in vitro and the analysis of heterozygous KLF16 knockout mice in vivo indicate that KLF16 is an inhibitor of osteogenic differentiation.</p>
<p>The integrated analysis of iPSC bulk transcriptomic data is a major strength of the study, and it is also great that the authors provide deeper functional characterization of the transcription factor KLF16, one of the newly identified candidate regulators of osteogenic differentiation.</p>
</disp-quote>
<p>We appreciate the reviewer’s summary and comments on the strength of our bioinformatic analyses of iPSC/MSC osteogenic differentiation and the deep functional characterization of the KLF16, as well as the novelty of our findings.</p>
<disp-quote content-type="editor-comment">
<p>However, characterization of KLF16 expression in the mouse and validation of the knockout model are currently lacking. Alternative explanations for the mutant phenotype should be considered to improve the strength of the conclusions.</p>
<p>If all issues can be addressed, the study would provide an important resource for the field that would facilitate future research on the regulation of osteogenesis in vitro and in vivo, with potential implications for preclinical and clinical research as well as bioengineering.</p>
</disp-quote>
<p>We appreciate the reviewer’s valuable suggestions. <italic>Klf16</italic> is highly expressed in mandibular, maxillary and tail mesenchyme at embryonic Day 12 (D'Souza et al., 2002), indicating its role in early bone development. We will further characterize the expression of <italic>Klf16</italic> in mice, especially in the developing bones.</p>
<p>We identified <italic>Klf16</italic> as a potential regulator of osteogenic differentiation, and then validated this with both in vitro and in vivo models. Overexpression of <italic>Klf16</italic> suppressed osteogenesis in vitro, and <italic>Klf16<sup>+/-</sup></italic> mice showed increased bone mineral content and density, indicating its regulatory role in bone formation. We agree with the reviewer that the bone phenotypes of <italic>Klf16</italic> knockout mice potentially can be affected by other factors in addition to osteogenic differentiation. As both bone formation and resorption are critical for bone development, we evaluated osteoclastogenesis in the <italic>Klf16</italic><sup>+/-</sup> mice by analyzing the expression of osteoclast marker CALCR and regulator RANKL in the femurs of the <italic>Klf16</italic><sup>+/-</sup> mice. Neither CALCR nor RANKL decreased in the bone of <italic>Klf16</italic><sup>+/-</sup> mice, indicating that osteoclastogenesis is not decreased; therefore, increased bone mineral content and density in the mutant mice is more likely attributed to enhanced bone formation rather than reduced resorption by osteoclasts. Additionally, we will discuss other alternative explanations for the bone phenotypes of <italic>Klf16</italic> knockout mice as suggested by the reviewer.</p>
<p>References</p>
<p>D'Souza, U. M., Lammers, C.-H., Hwang, C. K., Yajima, S. and Mouradian, M. M. (2002). Developmental expression of the zinc finger transcription factor DRRF (dopamine receptor regulating factor). Mechanisms of Development 110, 197-201.</p>
<p>Housman, G., Briscoe, E. and Gilad, Y. (2022). Evolutionary insights into primate skeletal gene regulation using a comparative cell culture model. PLOS Genetics 18, e1010073-e1010073.</p>
</body>
</sub-article>
</article>